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Abstract 
 
In this study, we present a potential alternative approach for the treatment of melanoma skin cancer and 
skin tissue regeneration. A comparison of polycaprolactone (PCL) and polycaprolactone blended with 
linear (LPEI) and branched polyethylenimine (BPEI). This research presents the biocompatibility and 
feasibility of PCL, PCL loaded with LPEI and PCL loaded with BPEI in different concentrations, producing 
electrospun scaffolds. SEM images show that the nanofibers developed between 271 to 419 nm. Contact 
angle assay demonstrated high hydrophobicity for all mats, which could be overcome by surface 
modification, namely, plasma treatment, ameliorating the hydrophilicity of the mats, providing excellent 
cells adhesion to the scaffolds surface. We demonstrate the biocompatibility of the scaffolds developed 
by electrospinning techniques, followed by in vitro tests with Human Dermal Fibroblasts (HDFs) and 
murine melanoma cells (B16), by using MTT assay 3-(4,5- dimethylthizol-2-yl)-5-(3-
carboxymethoxyphenyl)-2(4-sulfophenyl)-2H-tetrazolium to determinate the biocompatibility with all cells, 
and confocal images to give us insights of cell morphology (nucleus and cellular membrane). Sirius red 
collagen assay was performed for HDFs to give the collagen release profile after 6 days of incubation, 
and the possibility of the mats to help in skin regeneration process by forming extra cellular matrix (ECM). 
The CFMDA dye suggested no cytotoxicity for HDFs to monitor the morphology of live cells. The results 
have shown that all the scaffolds developed have good cell adhesion and proliferation properties. We 
could also observe high cytotoxicity for B16 melanoma cells for PCL_2BPEI scaffolds. This primary in 
vitro study suggests that the mats developed may increase the skin regeneration process and at the same 
time promote apoptosis of melanoma cells. 
 
Keywords: Electrospinning, drug delivery, melanoma, scaffolds, tissue engineering. 
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RESUMO 
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Resumo 
 
Neste estudo, apresentamos uma abordagem alternativa como potencial tratamento para o câncer de 
pele melanoma e regeneração do tecido da pele. Uma comparação de policaprolactona (PCL) e 
policaprolactona misturada com polietilenoimina linear (LPEI) e ramificada (BPEI). Esta pesquisa 
apresenta a biocompatibilidade e viabilidade de PCL, PCL carregado com LPEI e PCL carregado com 
BPEI em diferentes concentrações, produzindo estruturas de suporte eletrofuncionais. Imagens de SEM 
mostram que as nanofibras se desenvolveram entre 271 e 419 nm. O ensaio de ângulo de contato 
demonstrou alta hidrofobicidade para todas as nanofibras, o que poderia ser superado por modificação 
de superfície, ou seja, tratamento com plasma, melhorando a hidrofilicidade das nanofibras, 
proporcionando excelente adesão celular à superfície das estruturas de suporte. Demonstramos a 
biocompatibilidade das estruturas de suporte desenvolvidos por técnicas de eletrofiação, seguidos por 
testes in vitro com fibroblastos dérmicos humanos (HDFs) e células de melanoma murino (B16), usando 
o ensaio MTS 3- (4,5-dimetiltiazol-2-il) -5- (3-carboximetoxifenil) -2 (4- sulfofenil) -2H-tetrólio para 
determinar a biocompatibilidade com todas as células, e imagens confocais para dar como insights da 
morfologia celular (núcleo e membrana celular). O ensaio de colagénio vermelho Sirius foi realizado para 
HDFs para dar o perfil de liberação de colagénio após 6 dias de incubação, e a possibilidade das 
estruturas de suporte ajudarem no processo de regeneração da pele através da formação de matriz 
extracelular (ECM). O corante Diacetato de CFMDA-5-clorometilfluorescea sugere não citotoxicidade das 
células HDFs monitoradas. Os resultados mostraram que todas as estruturas de suporte desenvolveram 
boas propriedades de adesão e proliferação celular. Também pudemos observar alta citotoxicidade para 
células de melanoma B16 para estrutura de suporte PCL_2BPEI. Este estudo in vitro sugere que as 
estruturas de suporte desenvolvidas podem aumentar o processo de regeneração da pele e ao mesmo 
tempo promover a apoptose das células do melanoma. 
 
Palavras-chave: Eletrofiação, liberação de drogas, melanoma, estrutura de suporte, engenharia de 
tecidos. 
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1 CHAPTER  
 
INTRODUCTION 
 
Nanotechnology is the science of materials at nano level. Nowadays, this technology is one of the fastest 
growing in the world, since is possible to create new material with advanced applications that may be 
used in many different fields. 
Since the beginning of our civilization, man has had the need to establish dominance and the use of 
techniques in the manipulation of materials such as during the Stone Age, Bronze Age and further, the 
Iron Age (Zarbin, 2007). 
The term nanotechnology was first used by Taniguchi in 1974, the publication of his work entitled “On 
the Basic Concept of Nanotechnology” is the combination of knowledge of materials at the Nano-scale or 
approximately 1-100 nanometers (Kennedy, et. al., 2003). 
“Imagine a medical device that travels through the human body to seek out and destroy 
small clusters of cancerous cells before they can spread. Or a box no longer than a sugar 
cube that contains the entire contents of the Library Congress. Or materials much lighter 
than steel that possesses ten times as much strength”.  
U.S National Science Foundation 
By using nanotechnology, it is possible to create things from very small raw materials, atoms and 
molecules which later, can be rearranged as desired propose. It is not a specific technology, but it is a 
set of techniques that are based on fundamentals of chemistry, biology, physics, materials engineering 
and computing, extending the human capacity to manipulate matter on an atomic level. 
The technology of the 21st century is known as the “Nano World”, with a greater scientific knowledge and 
greater understanding of the subject from the 90´s. 
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The word nanotechnology is used to define the various scientific and technical aspects that compromise 
Nanoscale materials, working and manipulating molecular structures and their respective atoms, or 
allowing the ability to build new materials and machines by the reorganization of atoms and molecules. 
Nanomaterials are materials which have at least one dimension with a size less than 100nm (1nm= 
0.000001mm), namely 80,000 times thinner than a human hair. A nanometer width is equivalent to 
three or four atoms, while nanotechnology refers to dimensions between 1 and 100 nanometers. 
Currently, nanotechnology is being used in diverse areas ranging from medicine to the application and 
development of functional textiles. Here we can mention some companies that have large applications in 
nanotechnology are: 
• Ciba Specialty Chemicals: has a line of products for encapsulating nanoparticles molecules on 
textile with antimicrobial purposes; 
• Nano-Tex: technology developing nanoparticles to adhere to cotton or synthetic fibers; 
• Nano- X: encapsulating nanoparticles for application in protective textiles; 
• Schöller textiles: applications in nanoparticles for coating textile aiming to repel water and dirt. 
The Nano-scale materials are of great importance regarding the development of functional textiles. It has 
great economic and commercial potential for the textile industry. By using nanotechnology, we can create 
and manipulate Nanofibers, Nanofilaments, Nanoparticles, Nano capsules, depending on their purpose. 
The use of this technology provides to the textile market, not only in Europe but also to the rest of the 
world, many possibilities to the product become more competitive, at low cost with increased profit 
margins. These are textile with high activity potential and better performance materials, which encourage 
these companies to invest constantly in research on new technologies, increasing competition and the 
development of this market, with the objective to meet specific needs of certain target group or 
application. 
1.1 General Propose 
This Ph.D. thesis proposes the conception and the development of new electrospun mat which has 
cytotoxicity (for melanoma skin cancer cells) and regenerative properties for human dermal fibroblast to 
achieve wound healing and skin regeneration by collagen release. The scaffold is thought to apply directly 
onto the injured area, which will ensure the delivery of therapeutic preparations with therapeutic effect 
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and dose into tumour cells and surrounded cells, whereby it may become an alternative treatment 
efficacy. This thesis involves two areas, namely, Human Medicine and Biomedical Materials Engineering.   
The scaffold was produced by biodegradable polymers, approved by Food and Drugs Administration (FDA- 
the USA), the basis of which will be incorporated into composites electrospun mats, as an effective 
approach to treat melanoma cell in vitro, that will be an alternative approach in a near future to use for 
patient’s, without requiring the use of invasive techniques, leading to a more efficient recovery and 
decrease the patient’s malaise.  
The composite electrospun mats are thought to work as drug delivery system (DDS), which can be made 
by the combination of different polymers. The anticancer activity for melanoma skin cancer will be tested, 
serving as a potential drug delivery vehicle for treating this specific disease. The electrospun mats can 
deliver efficiently the drugs little by little, promote good cell adhesion and good interaction of matrix to 
cells, and promote skin tissue regeneration, thus enabling accumulation of the drug in the target 
melanoma cells. 
This Ph.D. thesis is of a great importance to the scientific field, since it is innovative and can serve as an 
alternative approach for patients which have been diagnosed with melanoma cancer. This might be in 
the near future a less invasive approach than the traditional therapies available on the market nowadays, 
such as chemo and radiotherapies.  
1.2 Specific Goal 
The specific goal of this Ph.D. thesis is to develop a scaffold with anticancer property to approach 
melanoma skin cancer in an early stage (in vitro). This study is thought to be useful and tested further in 
vitro and furthermore in human trials on the next few years. The scaffold should possess high cytotoxic 
properties of melanoma cells meanwhile promoting the growth and proliferation of healthy cells, as 
fibroblasts, aiming the skin regeneration. The skin regeneration can be achieved by expression of collagen 
by fibroblasts cells, once that collagen is the main structural protein in the extracellular space in several 
connective tissues in the human body, especially in the skin.  
In resume, this thesis seeks: 
• To explore the concepts of electrospun mats developed to the biomedical application; 
• Investigate the anticancer properties of different composites mats; 
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• Develop an effective drug delivery system for melanoma skin cancer therapy; 
• Investigate the regenerative properties and its possibility to apply as wound healing; 
• Investigate the biocompatibility of the composites with healthy living cells; 
• Prove the effectiveness of the investigated composite electrospun mats; 
• Create new approach and scientific foundation for the development of the biomedical application 
of scaffolds, developed by electrospinning technique and its functionality. 
1.3 Justification of the Work 
Melanoma skin cancer is by far the most aggressive form of skin cancer. Especially in the United States, 
Australia, New Zeeland and Brazil, the incidence of this type of cancer continues to rise, although this is 
a worldwide issue. The American Cancer Society reported that it is estimated that 76,100 new cases of 
melanoma per year only in the USA and, approximately 9,710 people are expected to die due to the 
aggressive and metastatic form of melanoma.  
On the past melanoma was known to develop mainly in older age group, particular men over the age of 
65. In recent years, melanoma has been reported to be developed in young adults, especially women 
with age ranging from 25-39 years. This is pronounced increase in incidence rates, with bad prognosis if 
is not diagnosed in early stages, often with severe outcomes. 
Sun exposure is the major risk factor for melanoma cancer, especially in tropical countries, although the 
incidence of melanoma can also be related to others factors that influence incidence rates, such as 
immunosuppression, genetic susceptibility, family history of melanoma and environmental factors. 
Chemotherapy treatment was the mainstay approach option for the advanced- stage melanoma, prior to 
the recent therapeutic advances. Several studies have investigated various chemotherapy combinations, 
as well radiotherapy in other to expand the clinical responses, but these appears to be not effective in 
overall survival rate. In addition to that, most of these therapies can worsen the patient health condition, 
due to invasive approach. Chemo and radiotherapies can promote apoptosis of malignancy cells, but at 
the same time have the apoptotic effect in healthy surrounding cells.  
In this way, it appears pertinent and current the need to mediate a new version for the treatment of 
melanoma, in relation to the existing methods available on the market. In addition, it is pertinent to 
evaluate the release and efficiency of the controlled drugs through scaffolds, namely electrospun mats, 
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using biodegradable and biocompatible polymers for its formulation and development. Therefore, 
reducing the use of invasive therapies such as chemo and radiotherapies. 
In this context, the main objective of this work was defined as the development of a new alternative 
approach for melanoma skin cancer, which can provide apoptosis of malignancy cells, accelerate the 
wound healing process and promote skin regeneration through the interaction of cells to cells and cell to 
the matrix, focusing the growth and proliferation of healthy cells, providing good adhesion of cells to the 
scaffold surface and nutrients supply necessary for human dermal fibroblast cells proliferation, and 
collagen expression. 
1.4 Applied Methodology 
Firstly, a theoretical study through literature review was conducted in order to comprehend and define 
the problems, regarding the Melanoma Skin Cancer treatment. 
In a second stage an exploratory research to characterize the problem and suggest solutions via in vitro 
studies, that may be useful in the near future as a less invasive approach with a minimized side effect to 
patients undergoing cancer treatment, namely melanoma. 
The third stage included the development of copolymer nanofibrous scaffolds in different concentrations. 
Therefore, we conducted characterization and influence of certain parameters as: 
• Process parameters variables: Electrical potential, flow rate, the concentration of the solution and 
distance between the Taylor Cone and the collector; 
• Environmental parameters which affect the process: velocity of the air in the chamber, moisture, 
and temperature; 
• Operating parameters: rate flow, electric field strength and the electric current. 
Quantitative analysis, FT-IR, water contact angle, mechanical properties and morphological 
characterization of the scaffold by SEM. 
In vitro studies were performed to provide reliable data of toxicity for melanoma cells B16, and 
biocompatibility cells of human dermal fibroblasts for all electrospun scaffolds developed. The collagen 
release profile was also investigated. We made all the practical and experimental work to produce and 
test electrospun scaffolds with all the desired properties. 
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1.5 Outline 
This thesis is divided into five chapters, starting from the literature review to the practice and realization 
of this research work. The chapters developed are here particularized as follow: 
• Chapter 1. Refers to the framing of the thesis. In this sense, the specified problematic synthesis 
of the existing information, specific goals for this proposed research, the justification of the work, 
the methodology used, such as the structure of the thesis. 
• Chapter 2. We conducted a literature review and the state of the art regarding melanoma skin 
cancer. This chapter is crucial to understand the importance of the contribution for the scientific 
community. For this reason, we divided this chapter into four main topics. Firstly, we present an 
overview of skin morphology, including some types of skin cancer such as Basal Cell Carcinoma 
(BCC), Squamous Cell Carcinoma (SCC) and Melanoma which is the main focus of this doctoral 
thesis. In this context, it was important to elucidate the melanoma microenvironment, the 
association of melanoma cancer development associated to human dermal fibroblasts, 
melanoma initiation, and progression through hypoxia-inducible factors (HIF), TAMs, and some 
conventional therapies mostly used to treat cancer as chemo and radiotherapy. In the second 
part of this chapter we introduce the nanofibers composites. We briefly explain the fabrication 
methods, the nanofibers properties, and an overview of the FDA approved composites used to 
conduct the practical part of this thesis. We detail the polycaprolactone (PCL) and Linear 
Polyethylenimine (LPEI) and Branched Polyethylenimine (BPEI). The third part is dedicated to the 
biomedical application of nanofibers composites. Here we elucidate some important 
characteristics of drugs delivery system, the permeation drug´s pathway, the implication of 
electrospun based materials for DDS in healthcare, used in wound healing process and cancer 
therapy. Last but not least, we present the biofunctionalization of fibrous electrospun scaffolds. 
We also report the characterization of cells to nanofiber, some cytocompatibility assays as MTT 
and MTS, and the cells used in this research work. 
• Chapter 3. We clarify the experimental part of the thesis and different assays that we used to 
develop the practical part. We present the development of the electrospun mats, the 
characterization of the scaffolds developed such as water contact angle (WCA), morphological 
characterization of the electrospun mats by SEM imaging, FT-IR, and determination of mechanical 
properties. This is followed by the description of cell culture methods, including human dermal 
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fibroblasts and murine melanoma cells (B16). It is also reported the biocompatibility assays used 
as CMFDA, Sirius Red Collagen, and MTS.  
• Chapter 4. We conduct detailed interpretation of all outcome data obtained from the above-
mentioned experiments. 
• Chapter 5 presents the final considerations, an overview results for this thesis and future research 
guidelines.  
The present study starts with a perspective of developing a more efficient biomaterial for the treatment 
of skin cancer, as a more efficient alternative than the traditional approaches as radio and chemotherapy, 
aiming to avoid side effect and at the same time promote the regeneration of tissue, acting as support 
for extracellular matrix (ECM). 
1.6 Original Contributions 
During these years, part of this study has been presented and recognized by the scientific community, 
through the following listed original contributions in international journals, conferences, and books: 
Articles in Scientific International Journals 
• Naves, L. B., Almeida, L., Ramakrishna, S. (2017). Understanding the microenvironment of Melanoma 
cells for the development of target drugs delivery systems. European Medical Journal- Oncology, 5(1), 
pp. 85–92.  
• Naves, L. B.; Dhand, C.; Almeida, L.; Rajamani, L., Ramakrishna, S. (2017). Linear and Branched 
Polyethynimines for skin regeneration treatment In Vitro Study. J Pharm Drug Deliv Res, 6(4), 73. 
Available in: http://doi.org/10.4172/2325-9604-C1-020  
• Naves, L. B., Almeida, L., Marques, M. J., Soares, G., & Ramakrishna, S. (2017). Emulsions 
Stabilization for Topical Application. Biomaterials and Medical Applications, (65), pp. 1–7.  
• Naves, L. B., Dhand, C., Venugopal, J. R., Rajamani, L., Ramakrishna, S., & Almeida, L. (2017). 
Nanotechnology for the treatment of melanoma skin cancer. Progress in Biomaterials, 6(1–2), pp. 
13–26. Available in: http://doi.org/10.1007/s40204-017-0064-z  
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• Naves, L. B., Dhand, C., Almeida, L., Rajamani, L., Ramakrishna, S., & Soares, G. (2017). Poly(lactic-
co-glycolic) acid drug delivery systems through transdermal pathway: an overview. Progress in 
Biomaterials, 6(1–2), pp. 1–11. Available in:  http://doi.org/10.1007/s40204-017-0063-0  
• Naves, L. B., Dhand, C., Almeida, L., Rajamani, L., & Ramakrishna, S. (2016). In vitro skin models 
and tissue engineering protocols for skin graft applications. Essays in Biochemistry, 60(4), 357 LP-
369. Available in: http://doi.org/10.1042/EBC20160043  
• Naves, L. B., & Almeida, L. (2015). Wound dressing for melanoma skin cancer therapy. Autex 
Research Journal. Available in: http://doi.org/978-606-685-275-3  
Articles in the Proceedings of International Conferences 
• Naves, L. B., Dhand, C., Almeida, L., Rajamani, L., Venugopal, J., Ramakrishna, S. (2017). 
Polycaprolactone blended with Linear and Branched Polyethyleneimines scaffolds for skin 
regeneration treatment- In vitro study. In Proceedings of International Conference and Exhibition on 
Nanomedicine and Drug Delivery, Osaka (JP). Available in: 
https://www.omicsonline.org/abstract/polycaprolactone-blended-with-linear-and-branched-
polyethynimines-scaffolds-for-skin-regeneration-treatment-in-vitro-study/ 
• Naves, L. B., & Almeida L. (2015). Wound healing dressing and some composites such as zeolite, 
TiO2, chitosan and PLGA: A review. In Proceedings of the World Academy of Science, Engineering and 
Technology, Miami (USA). Available in https://waset.org/author/l-b-naves 
• Naves, L. B., & Almeida, L. (2015). New Approach for melanoma skin cancer controlled releasing 
drugs for neutron capture therapy: A review. In Proceedings of The Fiber Society 2015 Fall Meeting 
and Technical Conference, Raleigh (USA). Available in 
http://thefibersociety.org/Portals/0/Past%20Conferences/2015_Fall_Abstracts 
• Naves, L. B., Roshan, P., & Belino, N. (2014). Functional design as a tool for children undergoing 
chemotherapy treatment. In Proceedings of the Global Fashion Conference 2014, Ghent (BE). 
Available in: http://doi.org/978-989-20-5337-0 
Books  
Naves, L. B., & Almeida, L. (2015). Approaching Skin Cancer Through Textile Engineering Perspective - 
A Review (1st ed.). Saarbrücken: LAP LAMBERT Academic Publishing.  
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Chapter in Books  
• Naves, L. B., Almeida, L., & Rajamani, L. (2017). Nanofiber composites in skin tissue engineering. In 
Nanofiber Composites for Biomedical Applications (1st ed., pp. 275–300). Chennai - India: Elsevier 
Woodhead Publishing. Available in: http://doi.org/10.1016/B978-0-08-100173-8.00011-9 
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2 CHAPTER 
 
LITERATURE REVIEW AND STATE OF THE ART 
 
2.1 Skin Cancer Problem 
2.1.1 Contextualization of the Problem 
One of the most aggressive types of skin cancer is Melanoma. The melanoma cancer is originated from 
the malignant transformation of melanocytes. It has low survival rate, easy to relapse and a notorious 
high multidrug resistance (MDR). In 2014, only in the United States, it has been reported that nearly 
76,100 people were diagnosed with new cases of melanoma, and estimation of 9,710 was expected to 
die. The trend worldwide is to use more and more drugs and nanotechnologies, for biomedical 
applications (Naves et al., 2017a).  
Nanotechnology is the field of applied science focused on the design, development, fabrication, 
characterization, and application of devices and materials in nanoscale. It has been shown a potentially 
significant impact of nanotechnology on healthcare by delivering changes in drugs delivery, disease 
monitoring, and diagnosis, regenerative medicine, implants, as well as research tools for biomedical 
science and drugs delivery. The use of nanotechnology in the healthcare environment can create new 
alternative treatments, minimizing the side effects, more efficient due to the target compounds, 
consequently minimizing the drug dosage and the treatment cost either to the patient or to the 
government. In addition to that, nanotechnology has been applied to most conventional melanoma 
therapies. 
In the last few years the researchers have been focusing their research on discovering new alternative 
approaches to treat cancer using nanotechnology. This approach has demonstrated that nano delivery of 
drugs for chemotherapy, immunotherapy, target therapy and photodynamic therapy has increased the 
treatment efficacy. In 2017, Naves and his co-workers stated:  
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“Targeting in nanotechnology refers to the spatial localization of the nanoparticles within 
the intentional sites and is distinct from molecularly targeted drugs. Targeted drug means 
blocking essential biochemical pathways or mutant proteins that are required for tumour 
cell growth”.  
(Naves et al., 2017a) 
Nanofibers have been incredibly used for the biomedical and sustained drugs delivery systems (DDS). 
Nanofibers are ideal for this approach due to their characteristics, their dimensions are similar to the 
components of the native extracellular matrix, possibility to mimic the fibrillar structure, which can provide 
essential cues for cellular survival and organization functions. 
Based on melanoma skin cancer issue, we propose to develop a new alternative approach for the 
treatment of this type of cancer, which will be developed by using electrospinning technique and ascertain 
that the scaffolds have some specific characteristics for biomedical application, such as cytotoxicity to 
malignancy cells, biocompatibility with healthy cells, acting as tissue regeneration, working as an 
extracellular matrix, providing great cells adhesion, growth and proliferation rate with the necessary 
nutrients supply. The main goal of this Ph.D. thesis is the development of a less invasive and more 
effective approach for the treatment of melanoma skin cancer. The essays in this thesis will be carried 
out in vitro only. 
2.1.2 Skin Morphology 
Skin is the largest organ in the human body, in adults, it represents 8% of their total body mass and has 
the surface area of about 1.8 m2. The skin is mainly composed of three different layers, namely the 
epidermis, dermis, and hypodermis as we can observe in Figure 2-1, these layers are mainly composed 
of nerves and blood supply. All these layers are responsible for protection from the risk that might be 
posed by thermoregulation and surrounding environment (Naves, 2013). The main two layers are the 
epidermis and dermis. The epidermis is outer layer, surrounded by extracellular lipid matrix, corneocytes 
and keratinocytes (which produce keratin), both packed into the extracellular lipid matrix (arranged in 
bilayers) some studies reported this arrangement as “brick and mortar”, separated from the dermis by 
basement membrane, and melanocytes (which provide pigmentation for the skin). The epidermis is 
responsible for promoting a protective barrier against bacteria or even harmful toxins. The dermis is 
located just under the epidermis, formed by a variety of connective tissues, as nerves, lymphatic system, 
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many types of cells and blood vessels (Elias & Menon, 1991). The dermis is formed by extracellular matrix 
(ECM), formed by glycosaminoglycans (GAGs), collagen and elastin. The functions are foremost as a 
barrier, working as a regulator for water retention and heat loss, sensory organ and preventing pathogens 
from entering the body. The primary type of cell found in the dermal layer is the fibroblast; these cells are 
responsible for synthesizing ECM proteins and enzymes, and activate the response to wound healing 
process by protease and collagenases. The innermost layer is called hypodermis, which is responsible 
for thermoregulation and mechanical properties of the skin (Boughton & Mclennan, 2013). In addition to 
that, skin is an attractive model to test novel drugs and regenerative medicine, with emphasis on skin 
tissue regeneration for chronic or acute wounds. The skin surface is a potential route for local and 
systemic drugs delivery, using either nanoparticles or electrospun mats. The delivery of the drugs can 
also be reached into opened follicles of the hair. One of the primary and most important functions of skin 
in mammalian is to provide a protective barrier against UV radiation, fungi, bacteria, and any nanoparticle 
that might come from the external and natural environment (Naves et. al., 2017a).  
Naves and Almeida (Naves & Almeida, 2015) stated: 
“In human’s skin, the hair follicles cover only 0.1% of the skin surface, however, target 
drug delivery can be performed through follicular route, to achieve a better drug 
penetration. By pulling out the hair sheath, it is possible to make a significant penetration 
of medicines in a size smaller than 40 nm into the epidermal cell, to reach, and facilitate 
a higher topical nanoparticle delivery through the skin. Mechanical stress on the skin is 
necessary, which can be achieved by massage, skin flexing, or follicles pulled out. Over 
the last few years, the interest in a target by follicular delivery has increased as it might 
be a potential delivery route into sebum to control the skin diseases.”  
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Figure 2-1 Schematic representation of the skin layers, namely the epidermis, dermis, and hypodermis. Source: (Grove, 2016) 
p.7. 
Topical drugs delivery systems have been investigated and practiced since the end of the 70´s, by using 
either nanoparticles or transdermal patches to be administrated as readily available skin localized therapy 
(Roy et. al., 1996).  
The pH of the skin surface is directly influenced by several factors such anatomical site, sweat, gender 
and hydration (Tinkle et al., 2003). Usually, the natural skin pH is around 4.2 to 5.6 (Schmid-Wendtner 
& Korting, 2006). The pH of the skin surface is very important for degradation of drugs when approaching 
it through the transdermal pathway, it also supports nanoparticles penetrations. Electrostatic force can 
be decreased by a solution with lower pH (Murphy et. al., 2010).  
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A natural process that occurs in the human skin is the desquamation, which happens in the Squamous 
Cells (SC) layers. The whole process of renewing the skin surface is completed in approximately 14 days. 
This process is very important for our protection, once that the corneocytes can provide elimination of 
certain matters such as pathogens, solid particles or even cancer cell. It is important to keep in mind, 
that the desquamation process may vary from one person to the other accordingly to the anatomy, 
malaise, and age (Naves et al., 2017a; Reddy, Guy, & Bunge, 2000). 
2.1.3 Types of Skin Cancer 
Our body is constantly making new cells, aiming growth, proliferation, replace dead cells, heal injuries 
and replace worn-out tissue. The cells, normally multiply and die in an orderly way. The cancer is formed 
by cells disease, when cells divide and proliferate in an abnormal way, which may lead to lymph or blood 
fluid in the body, thus, forming a lump called tumour. 
A tumour can be either benign or malignant. In the first type, the cells are not considered as cancer, once 
that the cells are confined to one specific area and they are not able to spread to other body sites. A 
malignant tumour takes place when is made up of carcinogenic cells, having the ability to spread through 
the body via the lymphatic system, also known as lymph fluid, and via the bloodstream. It is possible to 
observe at the upper part, how the cancer starts, by the proliferation of abnormal cells, when the 
angiogenesis takes place, cancer becomes invasive or malignant. 
The primary cancer is the type of cancer that first develops in a tissue or organ. A malignant tumour is 
named when a malignant tumour affects some type of cells or the organ. Differently, localized cancer is 
a malignant tumour that has not spread to the other body site. As mentioned above, in the angiogenesis 
process, the tumour may invade deeper the surrounding tissue, by vertical growth, and grow its own 
blood vessels. 
In Figure 2-2, it is also possible to observe how cancer spreads, also known as the metastatic effect. The 
metastasis or secondary cancer happens when the carcinogenic cells grow and form another tumour at 
a new body site. Always when there is a metastatic effect, it remains the name of original cancer. As 
example, we can mention skin cancer, when it spread to the lymph nodes is called metastatic skin cancer. 
Basal cell carcinoma rarely spreads, while squamous cell carcinoma and melanoma may easily lead to 
metastatic effect (Grove, 2016).  
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Figure 2-2 Schematic carcinogenic cells growth and proliferation, upper image. Representation of metastatic effect lower part. 
Source: (Grove, 2016) Adapted. 
It is well known that skin cancer is by far the most malignancy of humans, especially in the white 
population. It was reported that over a million cases are detected each year (D’Orazio et al., 2010). The 
skin cancer is named according to the clinical behavior and the cells which they arise from. The three 
commonest types will be better explained in this topic, we will give a greater focus on Melanoma, due to 
the purpose of this study.  
Briefly, the types of skin cancer are referred as nonmelanocytic skin cancer (NMSC) are: basal cell 
carcinoma (BCCs), and squamous cell carcinoma (SCCs). Cutaneous malignant melanomas (CMs), 
appears in the literature also reported as melanoma or malignant melanoma (Narayanan, Saladi, & Fox, 
2010). 
Skin cancer as many other types of cancers have increased the incidence significantly with age, 
environmental etiologies (UV exposure), and, reflecting long latency between cancer establishment and 
carcinogen exposure. Many cases of skin cancer remain not reported and the incidence of these type of 
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cancer continues increasing dramatically. In Table 2-1, it is shown a substantial underestimation of the 
epidemiological data. 
Reports from Europe and the United States, suggest that the incidence of NMSC is progressively 
increasing. Each year, worldwide, are expected 2-3 million cases of NMCs. The incidence may vary, 
although there is a high incidence in Caucasians population (Simões, Sousa, & Pais, 2015). The overall 
observed in most parts of Australia, Canada, Europe, and U.S.A, show that the incidence of skin cancer 
is increasing from 3% to 8% per year. Over the next 30 years, the incidence rate is expected to double 
(Rhee et al., 2007). In Europe, it is reported that NMSC mortality rate is lower in Nordic countries and 
higher in women and men in southern European countries such as Italy, Portugal, Greece and Spain 
(Boyle et. al., 2004).  
Table 2-1 Overview of epidemiological data of BCC, SCC, and CM. Source: (Simões et al., 2015) Adapted. 
Highlights of epidermal data 
Basal Cell Carcinomas (BCCs) Squamous Cell Carcinomas (SCCs) Cutaneous Malignant Melanoma 
(CMs) 
2-3 million cases of NMSCs occur worldwide each year (Narayanan, D.L., 
Saladi, R.N., Fox, 2010). 
Only in the U.S 1,3 million cases each year (Rhee et al., 2007) 
Rates are expected to double in the next 30 years (Rhee et al., 2007). 
NMSC mortality rate is lower in Nordic countries and higher in women and men 
in southern European countries such as Italy, Portugal, Greece, and Spain 
(Boyle et al., 2004). 
65 thousand people die per year 
worldwide (Narayanan, D.L., Saladi, 
R.N., Fox, 2010). 
highest rates in elderly men and 
increasing incidence in young women 
(O’Driscoll et al., 2006). 
Increasing rates, although it varies 
depending on the country (Lomas, 
Leonardi-Bee, & Bath-Hextall, 2012). 
Incidence rates are at least 16 times 
greater in Caucasians than African 
Americans and 10 times greater than 
Hispanics (Battie, Gohara, Vershoore, 
& Roberts, 2013). 
In the US, 30% of all new cancers 
diagnosed are BCC (Rittié et al., 
2007). 
SCC has higher possibility to invade 
other tissue and cause more death 
than BCC (Suárez et al., 2007). 
132 new cases worldwide will occur 
each year (Narayanan et al., 2010). 
In Figure 2-3 are presented images of Basal cell carcinoma and squamous cell carcinoma, both 
keratinocyte skin cancer, and Melanoma superficial and modular. It is possible to observe the difference 
regarding the color, the nodule and the shape of each type of cancer.  
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Figure 2-3 Images of skin cancer, namely BCCs, SCCs and melanoma superficial and nodular. Source: (Grove, 2016) p. 13, 
Adapted. 
2.1.3.1 Basal Cell Carcinoma (BCC) 
Basal cell carcinoma is related to 80-85% of all NMSCs. This type of cancer is the most common 
malignancy in the Caucasian population. In addition to that, it has a very low rate of mortality and 
metastatic effect to other body sites (Lang & Maize, 2005). Naves & Almeida stated (Naves & Almeida, 
2015):   
“… the incidence of UV rays are directed related to high risk of incidence of BCC skin 
cancer. However, the incidence of BCC is inversely related to inherent melanin content 
in the skin, serving as a protective function. It is uncommon for darker skin to get BCC.” 
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Controversially, if the population with darker skin suffers from albinism, which is when the melanocytes 
fail in the production of melanin, the risk of BCC incidence is substantially increased (Alexander & 
Henschke, 1981).  
Some physicians recommend exposure to ultraviolet light therapy for the treatment of some inflammatory 
skin conditions such as psoriasis, which has been also reported in the literature, that this type of radiation 
may cause an increase the BCC risk (Forman et. al., 1989).  
The treatment for BCCs mostly of the time is indicated with curettage and electrodesiccation (CE). 
However, when the patient has a recurrent tumour, tumour size larger than 2 cm, morpheaform tumours 
or in tumour in thickly hair-bearing areas, the electrodesiccation is not recommended due to its lower 
rate of success (Werlinger, Upton, & Moore, 2002). 
2.1.3.2 Squamous Cell Carcinoma (SCC) 
Reported as the second most common type of skin cancer, Squamous cell carcinoma, occurs particularly 
in the sun-exposed areas, such as neck and head. It has been reported that the majority of incidence of 
Squamous cell carcinoma, is caused and related to the mutation at the gene p53, which is the tumour 
suppressor. This mutation takes place by the ultraviolet light exposure (Sarasin & Giglia-Mari, 2002). 
Differently, from Basal cell carcinoma, the squamous cell carcinoma has a metastatic effect. 
Tward and co-workers, reported in their study (Tward et. at., 2012): 
“SCC begins with the squamous cells in the epidermis which are situated directly above 
the basement membrane where the basal cells are located in the stratum basale (…) as 
the keratinocytes, the squamous cells undergo an abrupt transition in the stratum 
granulosun of the epidermis where the intracellular keratin filaments clump, the cell 
undergoes programmed death, and a keratogenesis shell remains with intracellular was 
esters acting like “mortar” between keratinocyte “bricks” forming the water light barrier 
of the outer layer of the skin, the stratum corneum. Because of the abundance of keratin 
protein in squamous cells, in general, SCC is clinically much scalier and crusted than 
BCC.” 
It has been also reported that, due to the decrease of immunosurveillance, patients that underwent solid 
organ transplant and with lymphoproliferative malignancies become more prompt to develop SCC. As an 
example, we can mention patients who have done a renal transplant. The recipient of the organ is more 
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vulnerable, he has 7% of chance to develop SCC in the first year after the transplant. This rate increases 
to 45% after eleven years, and unfortunately, drastically, to 70% risk of incidence after 20 years of 
transplantation. When considering patients heart transplantation, this situation becomes worse, 2-3 times 
greater risk of SCC incidence compared to those, whose received renal transplant (Bouwes Bavinck et 
al., 1996). 
Both types of skin cancer BCC and SCC are related to the amount of ultraviolet radiation exposure 
received, and inversely proportional to the degree of skin pigmentation in the population, meaning that 
the darker the skin the lower is the incidence of NMSCs. Although many patients with NMSCs may remain 
undiagnosed and unregistered, the rate is increasing 10% worldwide, especially, in young women and 
older men individuals. The reported NMSCs are often found on sun-exposed areas such as head and neck 
(Diepgen & Mahler, 2002). 
2.1.3.3 Melanoma 
Melanoma skin cancer is one of the most common types of cancer. It is known that in women is the 
seventh leading cancer and in men is the fifth in the United States.  Annually, 800,000 people are 
expected to develop melanoma skin cancer. Over the last few years, the incidence of Melanoma skin 
cancer has increased substantially, especially in women. It is most common among Caucasians with 
green or blue eyes and blondish (Scotto, Fears, & Fraumeni, 1982). Approximately one in 100 newborns 
will at some stage of their lives develop malignancy in their lifetime (Kopf et. al., 1995). 
This type of cancer is the most aggressive skin cancer and represents only 3% of all diagnosed skin cancer 
in the United States. The high rate of patient’s death is related to advanced melanoma metastasis, which 
usually occurs several months up to years after the primary melanoma diagnosis. At an early stage, the 
melanoma tumour can be removed, therefore promoting a survival rate up to 99% (Naves et al., 2017a).  
When the patients are diagnosed with the late stage of melanoma, cancer may have a metastatic effect, 
thus, spreading the malignancy cells to the other parts of the body. 
When the rate of melanoma skin cancer is compared in terms of different races, the rate in Caucasians 
is 10 times greater than in Hispanics and 16 times greater than in African American. It has been reported 
that people with darker skin have higher mobility and fatality, when compared to other skin tons, once 
that they are undiagnosed for a while. In African American, the incidence rate is lower, because this group 
has increased epidermal melanin, resulting in a Sun Photoprotection Factor (SPF) of up to 13.4 in African 
Development of New Alternative Approach for the Treatment of Melanoma Skin Cancer  
CHAPTER 2: LITERATURE REVIEW AND STATE OF THE ART 
 
 21 
American skin. Another study suggested that the epidermal melanin can filter twice as much as UVB 
radiation in African Americans as does in Caucasians. 
In the literature review, it has been reported the incidence and correlation of UV radiation and melanoma 
rates. The UV radiation of sun exposure may cause irreversible damage; both UVA and UVB can damage 
directly and indirectly the DNA. Once these mutations occur in the DNA, they lead to the modification of 
the DNA, which will further develop skin cancer (Soehnge, Ouhtit & Ananthaswany, 1997). There are 5 
important factors that might affect the incidence of UVR levels reaching the earth’s surface such as: 
1. Clouds and others:  at higher cloud-cover densities there are lower UV levels. On the one hand 
pollutants, haze, and fog can decrease UV incidence by 10-90%, and on the other hand sand, 
metals, and snow can reflect it up to 90% (W. H. Organization, n.d.); 
2. Shades: the shadows may protect the UVR exposure for up to 90% according to different types of 
shade, e.g., dense foliage had the highest protection, while an umbrella at the beach shows low 
levels of solar radiation protection; 
3. Seawater: can reflect UV rays up to 15%; 
4. Latitude: living closer to equator zones increases the incidence of solar radiation, thus maximizing 
the probability of skin cancer incidence. The lower the latitude, the higher is the UVR incidence, 
on the other words, the UVR must travel a shorter distance through ozone-rich portions of the 
atmosphere and in turn, more UVR is emitted (Lautenschlanger,Wulf & Pittelknow, 2007); 
5. Altitude: every 1000m increasing in elevation, the UVR intensity increases by 10-12% (W. H. 
Organization, n.d.). 
In addition to the external process that may lead to skin cancer, the use of artificial UV tanning can also 
be linked to skin cancer development. Only in the US, approximately 28 million Americans are reported 
to use the artificial UV tanning. The exposure to the tanning bed and sunlamps have been warned to be 
carcinogenic by the National Institute of Environmental Health Science (NIEHS). The effects of UV 
exposure either natural or artificial may take 20 years to result in skin cancer (Chen et. al., 1998; Spencer 
& Amonette, 1995). In Figure 2-4 is possible to observe the UV index and alert in Australia, published by 
the Cancer Council of Australia (Grove, 2016). 
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Figure 2-4 UV index and alert in Australia. Source: (Grove, 2016) p. 16. 
Naves and co-workers, stated (Naves, Almeida, & Rajamani, 2017b): 
“In skin carcinogenesis, UV immunosuppression is considered an important event. The 
exposure to UV affects the skin immune system as delayed-type hypersensitive reactions, 
presenting cell function and inducing immunosuppressive cytokine production. Many 
cellular functions are provided by the p53 tumour suppressor gene, among all these 
functions we can distinguish transcription, cell cycle differentiation, regulation, and 
inhibition. The gene p53 is also responsible for DNA repair. Therefore, if the gene p53 is 
mutated, it will no longer aid in DNA repair process, as the result of this mutation, there 
is deregulation in the cellular cycle, and a proliferation of mutated keratinocytes, initiating 
skin cancer”. 
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Fortunately, this paradigm has changed due to the advances done in new pathways and targeting in drugs 
delivery systems (DDS), which may play a major impact on the development of immunotherapy and target 
therapy for melanoma cancer. The most common types of drugs used for the treatment of melanoma 
metastatic effect are ipilimumab and vemurafenib, both approved by the U.S. Food and Drug 
Administration (FDA), although both therapies still present their limitations. These drugs play different 
role targeting in melanoma cells, Ipilimumab can achieve durable benefits to the target cells by blocking 
the immune suppression of T cells which is induced by cytotoxic T lymphocyte antigen 4 (CTLA-4), 
however, around 80 to 85% of the patients do not respond to this therapy. Vemurafenib can achieve rapid 
tumour regression, targeting melanoma harboring BRAFV600E mutations. The negative side of this drug 
is that patients might have drug resistance after six months of treatment. In 2016, Wang and Yun, 
presented the melanoma network environment affecting the development of melanoma focusing the 
tissue hypoxia, macrophages and stromal fibroblasts (Wang & Yun, 2016). It is only possible to develop 
new drugs and strategies for melanoma therapy, prognosis, and diagnosis through a better understanding 
of how tumour microenvironment can directly affect the melanoma cancer progression.  
In a recent study published by Wang and colleagues (Wang et al., 2015), they reported the anticancer 
activity on melanoma cells of curcumin (CUR) loaded electrospun nanofibers with enhanced 
bioavailability. CUR, has many advantages, as anticancer activity and antioxidant (Bar-Sela, Epelbaum, & 
Schaffer, 2010; Maheshwari et. al., 2006; Shishodia, Chaturvedi, & Aggarwal, 2007). In this study, the 
authors used a water-soluble polymer polyvinylpyrrolidone (PVP) for the development of dissolution CUR, 
aiming the enhancement of the bioavailability. 
For the preparation of electrospinning solution, the researchers dissolved 1 g of PVP in 10 mL of acetic 
ether, then they loaded different concentration of CUR, related to the concentration of PVP in the solution. 
The CUR concentrations used in the study were 10%, 15%, and 20%. Using flow rate of 2 mL/h, the 
distance from the needle to the collector was 15 cm, and the voltage applied of 15 kV. 
They cultured murine melanoma cells line, known as B16. For the studies in vivo, they tested 48 male 
mice C57BL/6. For anticancer activity assay, the free CUR and PVP blended with CUR electrospun mats 
were administrated orally at a dosage of 25 mg/kg. The injection of B16 cells was inoculated and 
administrated as subcutaneous allografts, at a concentration of 1 x 106 B16 cells in PBS. The humanized 
euthanasia was carried to all mice after the study by pentobarbital sodium overdose injection. The tumour 
of each mouse was further dissected and kept in 4% formalin and PBS solution for fixation, of a tumour. 
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Under the excitation of 447nm CUR electrospun mats were observed giving the fluorescent red color 
Figure 2-5 (A), (B) and (C), the PVP nanofibers did not show any fluorescence, because it does not have 
this behavior. The FTIR spectra data is shown in Figure 2-5 (D) and (E). They reported that there was no 
sign of chemical changes as a result of electrospinning approach, either for CUR or PVP, retained their 
individual characteristics. In the FTIR analysis, significant peaks were attributed to intermolecular 
hydrogen bonding. Significant peaks can be observed, the peaks at 1602 and 1508 cm-1 are related to 
the aromatic stretching of C = C, CUR blended with PVP show 3600 – 3400 cm-1. 
In Figure 2-6, it is shown the anticancer histology images of a tumour induced by B16 cells. It is possible 
to make a comparison of three different tumour size, from the left to the right, we can observe the control, 
the tumour size of the mice treated with CUR electrospun, and tumour of mice treated with CUR blended 
with PVP. These last treated mice indicated a good anticancer activity and therapeutic effect. This data 
suggest that is possible to approach melanoma cancer through electrospinning technique.   
 
Figure 2-5 (A), (B), and (C) show the fluorescent images of CUR blended with PVP electrospun mats, 10%, 15%, and 20% wt% 
CUR, respectively. (D) shows FTIR spectra and (E) shows XRD data of nanofibers. Source: Open access doi: 10.1186/s11671-
015-1146-2. 
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Figure 2-6 Digital photo of tumour with the treatment of different samples at day 32, (b) tumour volume vs. time profile. Values 
are mean ± SEM (n = 20). **denotes significant differences (P < 0.01) against control group, ## denotes significant difference 
(P < 0.01) against CUR group. Open access doi: 10.1186/s11671-015-1146-2. 
2.1.4 Skin and Melanoma Microenvironment  
Skin is the largest organ of our body. The normal skin consists of two distinct layers: the epidermis and 
dermis.  
The epidermis is the upper layer formed by keratinocytes, melanocytes and Langerhans cells. 
Keratinocytes are the most abundant cell type in the epidermis layer; this type of cell is responsible to 
produce the major structural protein of the skin, many growth factors, and keratin to maintain the normal 
skin homeostasis. The keratinocytes cells also regulate and promote the proliferation of melanocytes 
through connexins, desmoglein-1 and E-cadherin (Li et al., 2003). The epidermal- melanocytes unit is 
formed normally by one melanocyte surrounded by 5-8 keratinocytes. Melanocytes cells are responsible 
to produce pigments called melanosomes containing melanin. The major risk of melanoma is the 
incidence and absorbance of ultraviolet (UV) radiation, upon UV exposure, the melanosomes are 
transferred from melanocytes to the keratinocytes, aiming to provide a mechanism that can avoid DNA 
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damages caused by UVR incidence (Kondo & Hearing, 2011).  In the skin is possible to find cells that are 
an antigen, namely, Langerhans cells that are the dendritic immune cells.  
The dermis is mostly formed by fibroblast cells, which are responsible for collagen production and release. 
In addition to fibroblast cells, we can find pericytes, adipocytes, macrophages and vascular endothelial 
cells. Fibroblast cells are also responsible to produce elastin, thus, maintaining thigh connection of the 
dermis and epidermis through a basement membrane. 
Melanoma microenvironment conditions differ from the normal skin, the condition is altered as the 
melanoma phase is progressing. In the early stage of melanoma, it is possible to observe radial growth 
phase (RGP), followed by vertical growth phase (VGP), subsequently, the last phase which might worsen 
the patient´s condition occurs at the metastatic stage. When we are talking about melanoma 
microenvironment is important to mention that it is highly heterogeneous, once that contains a variety of 
extracellular matrix (ECM), noncancerous cells such, fibroblasts, keratinocytes and inflammatory cells, at 
this microenvironment it is also possible to find growth factor produced by stromal cells and cancer cells. 
The interaction between the cancer cells and the surrounding cells is very complex. The cytokines and 
growth factor produced by melanoma cells are responsible to recruit many types of stromal cells, 
activating the tumour microenvironment, which can be either indirectly or directly. The first case, when 
the growth is indirectly it affects many functions of other types of stromal cells, which may play an 
important factor in melanoma initiation, progression, and finally metastasis. When a tumour is activated 
directly, the melanoma growth is promoted by activate stromal cells within the tumour microenvironment 
(Wachsberger, Burd, & Dicker, 2003). Figure 2-7, we can observe murine melanoma cells B16. 
Deprived of adequate oxygen supply, the hypoxia of dermal environment takes place, promoting 
melanomagenesis (Hockel et al., 1996). While the tumour grows, it is necessary to keep necessary 
nutrients, oxygen and blood supply, for this reason as a consequence, starts forming an uneven 
vasculature distribution (Wachsberger et al., 2003). Hypoxic tumour cells are often associated with worse 
prognosis, this kind of tumour is more resistant to radiation and chemotherapies, due to its peculiar 
biological properties and metabolic rates, once compared to well- oxygenated tumours (Harrison & 
Blackwell, 2004). The tumour aggressiveness and hypoxia are linked, in recent studies, researchers could 
demonstrate that tumours in the mouse when treated with antiangiogenic agents, can lead to tumour 
hypoxia, therefore, enhancing the invasion and migration properties (Bikfalvi et. al., 2011; Pàez-Ribes et 
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al., 2009). Tumour hypoxia and tumour- stromal cells microenvironment can play an important role in 
melanoma skin cancer initiation, progression, and treatment resistance. 
 
Figure 2-7 Confocal fluorescence images of B16 (murine melanoma cells). A-) Stained with Hoechst, to visualize the nuclei, 
blue; B-) cells stained with Phalloidin Rhodamine Actin, to visualize cellular morphology, red; C-) multiples layer. The confocal 
images were acquired by Zeiss LSM800 Airyscan microscope using x 63 oil immersion objective lens. 
2.1.5 Human Dermal Fibroblasts (HDF) and Melanoma Association 
The development of a melanoma tumour, the fibroblast cells can be activated by other types of stromal 
cells or tumour cells, playing an important role in tumour growth and progression. CAFs, are known as 
cancer-associated fibroblasts, which is highly heterogeneous in terms of their functions and markers. 
Commonly used in other cancers, the fibroblast-specific protein 1 (FSP1) is also expressed in melanoma 
cells (Andersen et al., 2004), for this reason it is possible to affirm that FSP1 is a good melanoma-
associated fibroblast (MAF) marker, once that it is induced by melanoma cells, although it cannot be 
detected in normal skin fibroblasts (Huber et al., 2003). Figure 2-8, shows healthy human dermal 
fibroblast after 24, 48 and 72 hours incubation time. 
 
Figure 2-8 High Content Analysis of Human Dermal Fibroblasts. A, B and C represent 24, 48 and 72 hours after incubation 
time, respectively. 
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Particularly in the white population, skin cancer is by far the most common malignancy of humans. 
Cutaneous malignant melanoma (CMs) is one of the three commonest types of skin cancer, the other 
types of skin cancer include non- melanocytic skin cancer- NMSC such as squamous cell carcinoma 
(SCCs) and basal cell carcinomas (BCCs). The vascularization of a tumour happens naturally, the cells 
obtain all the required nutrients to growth till reaching the size range of 2mm3, this is called passive 
diffusion (Jones & Harris, 1998).  
Melanoma cells growth and survival rates can be profoundly affected by MAFs. It was shown, in xenograft 
models, that co-injection of fibroblasts cells with melanoma cells increases the tumour growth (Gärtner, 
Wilson, & Dowdle, 1992). In another study, it was possible to observe that coculturing normal fibroblast 
cells in association with melanoma cells possibly promote the tumour growth, this growth has been 
reported in early-stage of the melanoma cells, on the other hand, it has a very little effect on melanoma 
metastatic cells (Cornil et al., 1991). Some fibroblast cells can promote growth factor by overexpression 
of insulin such as HGF, bFGF (Otsuka et al., 1998), and insulin growth factor-1 (IGF-1), leading to growth 
of biological early stages and inducing its survival rate of melanoma cells by activation of beta-catenin 
and mitogen-activated protein kinase (MAPK) (Satyamoorthy et. al., 2001). In addition to that, this growth 
factor also promotes vascular endothelial growth factor (VEGF) and epithelial growth factor (EGF), both 
are potent mitogens for melanoma cells growth, proliferation, and microenvironment. MAFs also promote 
the melanoma growth through glycosaminoglycan hyaluronan, which is also called as hyaluronate, 
hyaluronic acid or HA. The synthesis of HA (HAS1 and HAS2) in MAFs can activate and enhance 
melanoma production PDGF-CC and PDGF- AA, in dermal fibroblast, melanoma cell-derived factor 
stimulates hyaluronan synthesis by regulating HAS2 through p38 and PDGFR-PI3K-AKT signaling 
(Pasonen-Seppanen et al., 2012). HA is one of the major components of ECM and has been proved that 
HA can promote melanoma tumour growth, angiogenesis, and metastasis (Willenberg et. al., 2012). 
The ADAM-9 is expressed at tumour- stromal border, it is a family of proteases with a disintegrin and 
metalloprotease domain (ADAM). Studies in vivo and in vitro denotes that stromal fibroblast- specific 
expression of ADAM-9 is responsible for melanoma proliferation and apoptosis, at the same time is 
controversial whether it exerts tumour growth inhibitory effect or pro- tumour growth (Abety et al., 2012; 
Guaiquil et al., 2009).   
The gene p53 is related to several types of tumour, once that it can suppress the expression of the tumour 
suppressor (Bar et al., 2009). In stromal fibroblasts, the gene p53 can modulate the tumour growth in a 
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stromal cell-derived factor 1 (SDF1)- dependent manner (Addadi et al., 2010), dysfunction of p53 occurs 
in more than 90% of melanoma cases (Box & Terzian, 2008). In melanoma, MAFs may play an important 
role in metastatic effect, once that the invasive potential of human melanoma cells may alter the fibroblast 
gene expression (Bedogni & Powell, 2009). 
The metastatic effect is caused by the spread of the primary cancer cells to distant sites of the body, 
causing most of cancer deaths. In melanoma metastasis is possible to observe sequential steps listed 
below (Nguyen, Bos, & Massague, 2009; Orgaz & Sanz-Moreno, 2013): 
• Tumour cells are separate from the basement membrane, due acquisition of invasive phenotype; 
• Tumour cells can reach either regional site or distant organs through hematogenous or lymphatic 
dissemination; 
• Tumour cells survive in new metastatic organs such as bone, liver, brain, lungs, etc. 
Fibroblasts cells may play an important role in melanoma angiogenesis, which consists in the formation 
of new blood vessels to supply nutrients for tumour growth, being one step away from tumour cell 
metastasis. In a three-dimensional gel embedded with fibroblast type I collagen model and melanoma 
cells, normal human fibroblast enable melanoma cells to induce angiogenesis (Goldstein et. al., 2005). 
MAFs can enhance melanoma invasion and angiogenesis, as consequence, promote melanoma 
metastasis. 
2.1.6 Melanoma Initiation and Progression Through Hypoxia- Inducible Factors (HIF) 
Hypoxia-inducible factors are present in solid tumours when the malignant tumour size rage is more than 
1mm in diameter. As consequence, pockets of hypoxic regions can be visualized by 
immunohistochemistry with either CAIX (Pires et al., 2010) or pimonidazole (Post et al., 2004) or 
antibodies. Normal oxygen level in the skin ranges from 1.5 to 5% O2. This concentration of oxygen is 
sufficient for stabilization of HIF-1α (Bedogni & Powell, 2006). In the dermal-epidermal junction, the 
melanocytes are physiological hypoxic, under normal conditions, thereupon, hypoxia may play an 
important role in melanocyte transformation. In normal skin, the nuclear HIF-1α is detected and suggests 
that HIF-1α is activated in melanocytes, in other words, HIF-1α is a microphthalmia-associated 
transcription factor (MITF) transcription target in melanocytes (Buscà et al., 2005). MITF plays a crucial 
role in melanoma cancer progression, once it is a transcription factor that is involved in the regulation of 
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genes which are related to migration, invasiveness, proliferation survival and metastasis of melanoma 
cells. 
Known to induce tumour resistance to both radiation and chemotherapies, hypoxia has broad effects on 
tumour. Hypoxia encourages growth of cells with deficient function of tumour suppressor p53 (Lee et al., 
2013), promotes genetic instability, reduces drug-induced apoptosis (Schnitzer et. al., 2006), and favors 
growth of hypoxia-tolerant tumour cells clones (Brahimi-Horn, Chiche, & Pouysségur, 2007). 
HIFs may play an important role in melanoma tumour progression, chemotherapies resistance, and 
metastasis. Hypoxia can influence the metastatic progression, once it promotes a phenotype switch in 
melanoma cells from proliferative to invasive (Asnaghi et al., 2014). Proliferative melanoma cells once 
exposed to hypoxic microenvironment increase the invasive potential in a HIF-1α-dependent manner and 
downregulates melanocytic marker expression. Melanocytes are prone to oncogenic transformation under 
hypoxic microenvironment, due to HIF-1α stabilization. In vivo, under hypoxic condition, HIF-1α- deficient 
melanocytes show the ability to delay and diminished transformation capacity in tumour growth. Very 
aggressive melanoma can occur due to the expression of a nondegradable form of HIF-1α protein. A 
permissive environment of HIF-1α may act as a tumour promoter in cells, this activity is provided by 
enabling HIF-1α stabilization at low oxygen microenvironment in the skin, where tumour cells promoters 
have acquired oncogenic mutations and are genetically unstable. 
2.1.7 Tumour–Associated Macrophages (TAMs) 
The microenvironment of a melanoma tumour contains all types of inflammatory cells, including mast 
cells, neutrophils, dendritic cells, B and T cells, and macrophages. TAMs are the most abundant cell type 
among the immune cells, it can interfere directly to the tumour microenvironment by so many ways such 
as remodeling ECM, increase tumour initiation and growth, promoting angiogenesis and suppressing 
antitumour immunity through producing growth factors, cytokines, reactive oxygen and nitrogen species 
(NOS) and chemokines (Mantovani & Sica, 2010; Porta et al., 2007; Qian & Pollard, 2010). TAMs are 
also related to cancer resistance therapies as immune therapy, target therapy, radiotherapy, and 
chemotherapy. The patient’s response to antitumour therapies can be predicted by the number of 
macrophages, which is a prognosis maker, the higher number of infiltrating macrophages the worse is 
the prognosis in a variety of cancers, including melanoma (Torisu et al., 2000). An inflammatory 
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microenvironment plays an important role in every step of melanoma development, it can be provided by 
TAMS and highly inflamed tumours.  
The melanoma association with macrophages can be classified as (Wang & Yun, 2016): 
• M1 Macrophages – Activated macrophages: the macrophage is polarized by pro-inflammatory 
factors as IFN-ᵧ and microbial agents as bacterial lipopolysaccharide (LPS). In this macrophage, 
are produced reactive oxygen species (ROS), higher levels of nitric oxide (NO), TNF- α, IL-6, IL-
12 and lower level of immunosuppressive cytokine IL-10. Many growth factors produced by M1 
macrophages have a high effect on promoting tumour growth and metastasis such as IL-6 and 
TNF-α; 
• M2 Macrophages – Alternatively activated macrophages: TAMs resemble M2 macrophages and 
exert pro- tumour activity. M2 macrophages produce lower levels of IL-12 a higher level of TGF-
β, IL-1 receptor (IL-1ra), IL-10, CCL-1, CCL18, and CCL-22. 
2.1.8 Melanoma Therapy by Macrophages Targeting 
Many approaches have been developed to target macrophages in melanoma cancer, due to its 
multifunction and ability to promote tumour progression and metastasis, studying the mechanisms of 
macrophages on tumour development and the possibilities available to treat the patient´s tumour: 
• M-CSF Receptor Inhibitor: M-CSF is the most potent growth factor which is highly expressed in 
melanoma cell lines. It is related to melanoma- associated macrophages activating multiples 
survival signaling for macrophages, once it binds to the M-CSF receptor (M-CSFR). Currently 
undergoing clinical trials, several M-CSFR inhibitors are being tested for metastatic solid and 
advanced cancers, including melanoma. These trials focused on cancer therapy from tumour 
microenvironment and cancer cells to tumour cells are summarized in Table 2-2 . PLX3387, an 
M-CSFRi, was developed by Plexxikon Inc. It possesses the ability to increase the antitumour 
activity of BRAF1 inhibitors. So, phase I is under way for patients diagnosed with melanoma. Anti-
M-CSFR antibody, the AMG 820, from Amgen, are under trials for advanced solid tumour therapy. 
Also, used for treating a solid tumour, the M-CSFR inhibitor ARRAY-382 is also under clinical trial; 
                                                        
1 BRAF is a human gene that encodes the protein called B-Raf, which is involved in sending signals inside the cells for cellular 
growth. In some human cancer this protein is mutated. 
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• CCL-2 Inhibitor: CCL-2 plays an important role in macrophage survival and differentiation. It is 
the most potent chemoattractant for macrophages. For melanoma therapy, some studies indicate 
that anticancer therapies in combination with CCL-2 targeting are useful and vital (Hansen et al., 
2006). The expression CCL-2 can be decreased by the antitumour activity of BRAF inhibitors. In 
de novo tumourigenesis and mouse melanoma xenograft models can achieve the synergistic 
effect on tumour growth in combination therapy of an anti- CCL-2 antibody and BRAFi (Knight et. 
al., 2013); 
• Liposome- Based Assay: composed by a bilayer of phospholipid, the liposome is an artificially 
prepared vesicle structure. The drugs can be phagocytosed and recognized by microphages when 
loaded in liposomes, providing an efficient macrophage targeting. The liposomes have less 
toxicity than regular chemotherapy agents and can minimize the degradation of chemotherapy 
agents in the serum (Kelly, Jefferies, & Cryan, 2011). Liposome- encapsulate clodronate (LIP-
CLOD) sulfate, enable the macrophages apoptosis, the deletion of macrophages leads to the 
angiogenesis inhibition and melanoma growth in human melanoma xenograft model (Gazzaniga 
et al., 2007). In a study, reported by Banciu and co-workers, they stated that liposomal 
prednisolone phosphate has antitumour growth effect on deletion of TAMs in melanoma models 
(mouse B16) (Banciu et. al., 2008).  
Table 2-2 Summary of drugs that target macrophages. Source adapted from: (Tao Wang , Sook Jung Yun, 2016). 
Name Clinical indication Therapy Combination Pathway Phase 
PLX3397 Advanced solid tumours Paclitaxel M-CSFR I 
 Unresectable or metastatic melanoma Vemurafenib  I 
 Gliobastoma Termozolomide and radiation  I/II 
AMG 820 Advanced solid tumours NO M-CSFR I 
ARRY 382 Advanced solid tumours NO M-CSFR I 
 
2.1.9 Skin Cancer Treatments 
In the past decade, the therapeutic landscape has been rapidly changing regarding the process of skin 
cancer treatment. Target therapy, nowadays, is the hot topic, as an alternative to traditional cancer 
treatment such as chemotherapy and radiotherapy. Molecular- target drugs (e.g. MEK inhibitors, and 
BRAF inhibitors) and immune checkpoint agents (e.g. anti- PD-1, anti-CTLA-4), have been gradually taking 
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place of standard chemotherapy. The most used agent for chemotherapy treatment is the dacarbazine 
(DTIC). 
The National Comprehensive Cancer Network (NCCN), in 2017, has done some recommendation for 
patients with or without BRAF mutations, having unresectable stage III or stage IV for melanoma. The 
first-line setting to approach this type of cancer include immunotherapy with checkpoint inhibitors 
nivolumab (category 1) or anti-PD-1 monotherapy with pembrolizumab (category 2A), or ipilimumab/ 
nivolumab combination therapy (category 2A). Cancers with category 1, the recommendations include 
MEK/BRAF inhibitors combination therapy with cobimetinib/vemurafenib or trametinib/dabrafenib or 
monotherapy with vemurafenib or dabrafenib targeting BRAF inhibitors. BRAF – target- therapy shows 
good efficiency in patients with metastatic disease and BRAF mutations. Patients diagnosed with PS 0 to 
2 have multiple approaches, such as high dose of IL-2, BRAF/MEK inhibitors combination therapy if the 
patient has a BRAF mutation, chemotherapy, bio chemotherapy, anti-PD-1 monotherapy, 
ipilimumab/nivolumab combination therapy (Luo & Shen, 2017).  
Apart from the above-mentioned approaches in this thesis, we will make a more detailed approach to the 
topic of chemotherapy and radiotherapy treatment focused on melanoma skin cancer. These therapies 
are reported as causing, in some cases, severe side effect, leading to patient´s damage or worsening 
health condition. Most of these treatments available, can have the apoptotic effect to malignancy and 
healthy cells at the same time. For this reason, this doctoral thesis is of a great advantage for the scientific 
knowledge, proposing the use of electrospun mats for topical application, working as a drug delivery 
system, at the same time provide skin regeneration and collagen release for the damaged surrounded 
area. 
2.1.9.1 Chemotherapy 
Chemotherapy treatment is reported as being the combination of one or several drugs, it can be such as 
aspirin or penicillin, it will depend upon what kind of disease the physicians intend to treat. However, 
most people, which are not used to the term chemotherapy, often link its name to cancer treatment. The 
use of any kind and dosage of drug is related and may vary in how they are taken, the chemical 
composition, the possible side effects and last but not least, their effectiveness to a specific type of cancer. 
Depending upon the disorder, the physicians may decide for either the use of single drug or combination 
of multiple treatments or drugs. Last decade, Schulmeister and colleagues (Schulmeister et al., 2005), 
used a pre-documented protocol, aiming to reduce error regarding the prescription or the treatment, so, 
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for this reason, all chemotherapy based treatments should follow and be provided on the basis of 
protocols. 
Regarding the treatment of cancer cells, it is imperative a better understanding of the life cycle of a cell. 
It is known, that healthy cells have programmed and controlled lifecycle and carcinogenic cells cannot 
control, regulate their growth nor their interaction with the surrounding cells, thus, physicians may predict 
what is the best option for targeting a specific type of carcinogenic cells, if it is necessary the combination 
of multiple drugs, how often each drug should be administrated to the patients, and the dosage.  
The American Cancer Society (American Cancer Society Staff, 2015), has done an explanation regarding 
the cell life cycle which is divided into five phases described below: 
1. G0 phase (resting state): at this stage, the cell is not divided. Depending on the type of cell, G0 
can last from few hours to a few days. Cells spend much of their lives in this phase. When the 
cells get signals to reproduce, it goes further into G1 phase. 
2. G1 phase: this phase lasts about 8 to 30 hours. The cell starts making more protein, and, growing 
larger. 
3. S phase: this phase lasts about 18 to 20 hours, the chromosomes containing the genetic code 
(DNA) are copied, so that, both new cells will match the DNA standards.  
4. G2 phase: this phase comprehends from 2 to 10 hours, it is when the cell will check the DNA 
and get ready for starting to split into two new cells. 
5. M phase (mitosis): this phase lasts only 30 to 60 minutes. The cell split at this stage into 2 new 
cells. 
Chemotherapy is given to the patient through different pathways, depending upon the type of carcinogenic 
cells, most of the cases the patients receive the chemo dosage through the bloodstream or pills which 
can be taken. In some cancers, the chemotherapy is delivered directly to the patient´s body, where a 
tumour is located, aiming to deliver the drug directly to the affected body site and the same time, avoid 
the side effects. The side effects exist, especially when the drugs are taken through the bloodstream, 
once that the drugs can travel thought the body. As chemotherapy side effect we can mention: changes 
in mood or thinking, dehydration (lack of fluids), eating problems, falling, fatigue, fertility, fever, hair loss, 
hiccups, infection, leg cramps, low blood counts, lymphedema, mouth problems, nausea and vomiting, 
ostomies, pain, peripheral neuropathy, seizures, shortness of breath, skin problems, sleep problems, 
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stool or urine changes, sweating, swelling and weakness (American Cancer Society, 2017). The 
chemotherapy can be given to the patients through 3 main pathway ( Naves & Almeida, 2015): 
• Intralesional chemo: this kind of chemotherapy is often used for skin conditions, and for non- 
melanoma skin cancer such as basal cell carcinoma and squamous cell carcinoma. It is applied 
intralesional or via topical route, generally used for treating tumours locates under the skin, it is 
rarely used for cancers inside the body and when the surgery it is not the first option (Carrington, 
Stone, Koczwara, & Searle, 2010). 
• Intra-arterial chemo: this type of chemotherapy is used, aiming to target more efficiently the 
tumour body site, concentrating the drugs in a tumour, thus, minimizing the systemic side effects. 
This method is one of the most used to treat cancer in several organs. The method is given to 
the patients by a flexible catheter (portable pump or attached as an implant) positioned right in 
the main artery that supplies blood to a tumour. 
• Intracavitary chemo: it is related to the chemo which is given through a catheter, used to describe 
as chemo given right into a body cavity. This method as per se, is subdivide as: intravesical 
chemotherapy, intrapleural chemotherapy, intraperitoneal chemotherapy and intrathecal 
chemotherapy.  
In 2002, Baguley (Baguley, 2002) in the study entitled A brief history of cancer chemotherapy stated: 
“One of the most fascinating questions posed by dividing normal and cancer cells was 
the nature of the molecular clock that instructed the cell as to when it would replicate its 
DNA and when it would divide. Early studies in cancer tissue identified mitotic cells by 
their morphology and DNA- synthesizing (S- phase) cell by their uptake of tritium labeled 
thymidine (…) The first clues to the nature of the oscillator that ran the molecular clock 
were provided by the discovery in developing sea urchin eggs od a protein termed cyclin2. 
The cellular concentration of this protein increased up to the time of cell division and the 
abruptly decreased”. 
2.1.9.2 Radiotherapy 
Radiation therapy (RT) can be very beneficial when dealing with cutaneous malignancy. However, there 
are several oncologists and dermatologists whose have been hesitated to prescribe radiation therapy, due 
                                                        
2 Cyclin is necessary to cell division. 
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to many issues and side effects. One of the biggest reason has been reported by Tward and co-workers 
(Tward et. al., 2012) that some of the patients who underwent RT treatment in their youth, treated with 
Grenz Rays3, have gone to the development of some cutaneous malignancies later in their life. In RT, an 
electron beam energy should encompass a deep margin of a tumour by at least 90% distal, it is mandatory 
to choose an effective energy beam to achieve adequate surface dose. Mendenhall and colleagues 
(Mendenhall et. al., 1994) recommended for tumours smaller than 10 mm of a single radiation dose 
20Gy4, when the tumours are higher than 10mm is recommended the bean fraction, aiming to improve 
the therapeutically effect, minimize larger dose the tumour and avoid harmful radiation to the surrounding 
normal tissue (Lang & Maize, 2005). 
Up to date, the RT is no longer used as it was used in the past, although, remains as an important 
alternative for cancer treatment, especially when dealing with metastatic melanoma (MM).  It is reported 
in the literature that RT has been used as palliative treatment for MM (Gorayski et al., 2017).  
The management of MM is highly complex due to its poor response to cytotoxic systemic treatment and 
clinical variables course. These poor cytotoxic include the use of fotemustine, dacarbazine, and 
temozolomide (Walker et. al., 2014). Other options that still cause significant toxicity and have a low 
response rate is the immunotherapy with ipilimumab and interleukin-2 (Alva et al., 2016; Menzies & 
Long, 2017). 
The mutation test of tumour BRAF is a routine for all patients diagnosed with MM, thanks to the availability 
of agents targeting this intramolecular pathway. The overall survivals (OS) and prolongation of 
progression-free survival (PFS) are often linked to the use of BRAF inhibitors. The activation of BRAF 
protein kinase, once mutated, cause its activation in RAF/MEK/ERK pathway, therefore, stimulating 
cellular survival and proliferation (Dutriaux et al., 2015; Liszkay et al., 2014). 
RT utilization rates for MM patients may vary considerably. The palliative radiotherapy (RT) is commonly 
utilized in patients with MM to treat symptoms as improve local control, avoid local progression and 
prevent the pathological fracture from bone metastases. Some estimative has been made, suggesting a 
                                                        
3 Grenz rays are part of electromagnetic spectrum comprising low energy x-rays. 
4 The International Systems of Unit (SI) the Gray (symbol: Gy) is derived unit of ionizing radiation dose, which is defined as the 
absorption of one joule of radiation energy per one kilogram of matter. 
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rate around 21% of patients with established metastatic disease and 23% across all clinical stages (Lang 
& Maize, 2005). 
Some physicians do not use RT as it was reported, that radiation has the tendency to develop atrophy 
and telangiectasias5, as well the possibility of a further eruption of cancer over the time that might 
compromise the cosmetic appearance. In addition to that, RT may create a high risk for additional tumour 
formation, by damaging DNA of the cells (Gorlin, 1995). 
2.2 Nanofibers Composites 
2.2.1 Nanofibers Introduction 
Nanofibers are widely used in various medical biomedical application such as tissue engineering, cell 
therapy, regenerative medicine, drug delivery and cancer therapy which is the main goal of this doctoral 
thesis. These fibers have a diameter range of 1 to 100 nanometers when the diameter is higher than 100 
nanometers is called either electrospun mats or scaffolds developed by electrospinning technique. Thus, 
in terms of properties, scaffolds have proven to be much more efficient than any other system for 
molecular and cellular applications, as compared to their micro-macro scale. We can distinguish some 
functional properties, such as high aspect ratio, quantum confinement effects, large surface area, fast- 
absorbing biomolecules which provide abundant binding and adhesion to cell receptors. The strong cell-
matrix interaction allows developing cell engineering, organs and tissues (Yang et. al., 2005). Electrospun 
scaffolds possess among all their characteristics surface morphology, mechanical strength, structural 
integrity, chemical functionalities and porosity, these characteristics can be tailored, accordingly to their 
employed application by modulating the fiber orientation, material composition, dimension and 
alignment. Monophasic electrospun mats have some numerous advantages, however, for some 
biomedical application is required composites scaffolds owing superior functional and structural 
properties (Ramalingam & Ramakrishna, 2017). 
Several studies have been carried out on nanofibers composites, demonstrating that for biomedical and 
biological application, nanofibers composites are the better option than their monophasic nanofibers. 
When compared chitosan nanofibers to blended polycaprolactone (PCL)/chitosan, the cell proliferation 
                                                        
5 Telangiectasis is also known as angioectasias or spider veins, which consists in small dilated blood vessels near the 
mucous membrane or the surface of the skin.  
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increased (> 50%) and obtained better mechanical properties to the composite nanofibers 
polycaprolactone (PCL)/chitosan than the monophasic chitosan nanofibers system (Prabhakaran et. al., 
2008). Nanofibers composites are engineered materials composed of two or more distinct phase 
combined to impart new desirable, chemical, physical or even biological properties, processing bulk of 
different forms than those of any of the constituent phases. Ramalingam and Ramakrishna (2017) stated 
in Chapter 1: 
“The matrix and reinforcing phases are the two components of the nanofiber composites. 
The matrix phase (also called continuous phase) is the primary phase, which is usually more 
ductile and less hard, and the reinforcing phase (also called secondary phase or dispersed 
phase) is embedded within the matrix, which is usually stronger than the matrix phase, as 
the name implies. A synergism produces material properties available from the individual 
constituent phases, while the wide variety of available polymer nanofibers and reinforcing 
phases allow for the choice of the optimum combination for the specific application”. 
Statistical data shows the continuous development over the years for biomedical application research and 
development, as we can observe in Figure 2-9. 
 
Figure 2-9 Statistical data representation for continuous growth of nanofibers composites in the field of biomedical research 
and development.  
 
Nanofibers composites can be fabricated using various technique, such self- ensemble, phase separation, 
template synthesis and electrospinning. Among all these techniques, electrospinning appears to be the 
most widely used method, due to its ease fabrication, tunable structure and the possibility of large-scale 
fabrication. One of the most important characteristics is the resultant fiber is well suitable for a various 
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biomedical application. In Figure 2-10, we show the schematic representation of electrospinning 
apparatus. 
The fabrication of nanofibers to develop scaffolds by electrospinning method is made by using an 
electrostatically driven jet of charged polymer melt or polymer solution (Murugan & Ramakrishna, 2007). 
Briefly, by applying an optimized electrical potential to the spinneret, the droplet located at the edge of 
the spinneret tip, polymer solution, gets electrified. There is an accumulation of charge on the surface of 
the droplet, which will be subsequently deformed into the Taylor cone. The droplet deformation is caused 
by: 
1. Coulombic force, which is exerted by the external electrical field applied; 
2. Electrostatic repulsion within the charge of the surface droplet and the Coulombic force.   
The threshold occurs, when the electric field applied surpasses the critical value, the polymer electrostatic 
force at this stage tends to exceed the viscoelastic force and surface tension, consequently, is formed a 
very fine jet of charged polymer, which will be ejected from the tip of the Taylor cone.  
As we can observe at Figure 2-10, the negative electrode is also called as fiber collector, it is the direction 
which the polymer jet will move towards. The instability zone is the distance from the Taylor cone and the 
collector of the fibers is where will happen a rapid evaporation of the solvents molecules. Due to the 
mutual repulsion, while in transit, the different polymers strands in the jet get separated, this phenomenon 
is known as splaying, rising to a series of ultra-fine dry fibers. The fibers are can be collected at the fiber 
collector (grounded metallic target), the range size may vary from nanometer to micrometers. 
 
Figure 2-10 Schematic of electrospinning apparatus Source: (Wei et. al. 2011) adapted from p.119. 
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2.2.2 Nanofibers Composites Properties 
Without compromising their volume fraction, nanofibers composites when compared to conventional 
composites, have been demonstrated to have a significantly large surface area. This large surface area 
can be useful to compensate the imperfection bonding between the fiber matrix interphases; therefore, 
even when prepared with the same volume fraction, nanofibers composites offer greater strength than 
conventional composites. These composites structures could be subject to surface either modification or 
treatment to impart or enhance new functional properties within them. In Figure 2-11, we show some of 
the key characteristics of the nanofibers composites, which are very tunable, it will basically depend upon 
the application and the specific need of the nanofibers composites. As an example, we can mention the 
poly (lactic-co-glycolic acid) (PLGA) nanofiber biodegradability which can be easily fine-tuned by just 
manipulating the concentrations of lactic or glycolic. 
The interaction between the surrounding matrix and the nanofibers is one of the important factors that 
determine the composite properties interactions. These interface properties have been demonstrated to 
have the capability to control broadly properties, such as bonding strengths, bonding types and dislocation 
densities. The surface structure of each nanofiber will determine each nanofiber composites interface, 
therefore, every single electrospun mats surface will have a unique property (Ramalingam & 
Ramakrishna, 2017).  
 
Figure 2-11 Schematic of the key nanofibers composites. Source: (Ramalingam & Ramakrishna, 2017), adapted from p.6. 
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2.2.3 Physicochemical Characterizations at Materials Level  
One of the major features for characterization of electrospun mats is the fiber morphology, including 
diameter, alignment, shape (curved or straight; rounded or flat) and uniformity (uniform fibers of beaded). 
The morphology of prepared electrospun nanofibers can be fast screened by optical or light microscopy, 
to observe a nanofiber composite or a thin layer of nanofibers. Even though light microscopy is more 
convenient, it cannot achieve the high level of resolution and magnification as an electron microscope 
can. The typical resolution of light microscope is about 200nm. In addition to that, by using the light 
microscope is not possible to visualize the three-dimensional shape of nanofibers. Therefore, most of the 
studies are made using SEM for morphological characterization of electrospun composites (Polini & Yang, 
2017) 
The SEM technique is described in the literature as a technique that uses electrons, instead of visible 
light to produce images of the samples. SEM has the wavelength much smaller than visible light, 
considering the electrons, for this reason, this technique enables high-quality images with resolution less 
than 1nm. In addition to that, the SEM technique has a good depth of field thanks to a small aperture 
and large work distance. The sample, when scanned by a focused beam of electrons, the various signals 
at the sample surface, which is produced by the interaction of the sample and the bean, can further be 
collected, revealing some important sample information such as surface topography, morphology, and 
chemical composition. The secondary electrons (SE), X-rays characteristics and backscattered electrons 
(BSE) are the most useful signal detected by SEM. The images of SEM can have the contrast property 
useful for the qualitative analysis of the sample, once that the contrast is dominated by the so-called edge 
effect: the secondary electron at the edge leads to increased brightness at the location which is being 
beamed. To reveal the chemical composition of nanofibers composites the BSE mode is the more used 
tool. The atoms with greater atomic numbers (larger atoms), due to their greater cross-sectional area, 
have a higher probability of producing an elastic collision, resulting in more BSE production (Polini & 
Yang, 2017). So, when analyzing electrospun composite fibers, the polymeric fiber matrix appears less 
bright than metal particles or doped ceramic (Zhang, Cong, & Yu, 2012). The SE images, generally, have 
higher resolution than BSE images, as the BSE is emitted from the depth of the sample.  
Using SEM micrographs image analysis software, alignment and fiber diameter can be measured from 
microscopy images. The measurement of fiber diameters is made measuring multiple fibers of the 
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sample, the report result is described with ±, meaning the standard deviation, depicted as histograms of 
fiber diameter distribution (Ji et al., 2010). 
2.2.4 Surface Modifications  
The biofunctionalization of fibrous scaffolds is essential, the surface of electrospun fibers can be either 
incorporated with bioactive molecules or bioactive agents or even coated for use in advanced biological 
application with therapeutic properties. It is very important surface modification of the electrospun fibers 
for their use as antimicrobial or bioactive scaffold material (He et al., 2008; Kotaki et. al., 2005; Sadat, 
Amoabediny, & Ghaee, 2014; Song et. al., 2013; Wu et. al., 2010; Yao et. al., 2008). 
There are many natural polymers that can be employed, having unique biological functions improving the 
characteristics during the fabrication of electrospun scaffolds. In some cases, the release of the drug of 
hydrophobic therapeutic drugs, can be directly blended into the electrospinning polymer solution, to 
fabricate the fibrous scaffolds. When using synthetic biodegradable polymers, they all are hydrophobic in 
nature, so, when developing electrospun scaffolds aiming cell adhesion to the surface of the scaffold, it 
is imperative the surface modification, changing the surface property from hydrophobic to hydrophilic, 
thus, enabling the cell adhesion, proliferation, and growth on the surface of the mats. Researchers stated 
(Baji & Mai, 2017): 
“Typically, the hydrophilicity of the material can be improved by blending it with a 
hydrophilic polymer or by incorporating hydrophilic fillers within the matrix. However, a 
more straightforward technique is to improve the hydrophobicity of electrospun 
biodegradable polymer fiber using surface graft polymerization technique. Typically, 
plasma-induced polymerization can be used to graft polymer onto the surface of the fibers 
and modify the fiber surface chemistry and improve their hydrophilicity. This technique 
also introduces functional groups on the surface of the fibers that are used to bond 
covalently with bioactive molecules. The surface of the fibers is pretreated with UV 
irradiation to introduce polymer radicals to initiate graft polymerization of vinyl 
monomers”. 
In a study of surface modification reported by Yao and colleagues (Yao et al., 2008), they used poly(4-
vinyl-N-hexyl pyridinium bromide) to treat the polyurethane fibers. The polyurethane fibers were treated 
with the plasma treatment to produce peroxide and oxide groups to the mats surface, then, the fibers 
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were immersed in a solution of 4- vinyl pyridine monomer. Polyurethane fibers, were then, exposed to UV 
radiation, leading to the production of poly(4-vinyl pyridine), which were grafted into the polyurethane 
fibers. Followed these steps, the fibers were immersed into heptane solution containing hexyl bromide, 
thus, giving to the mats antimicrobial properties. In this study, the authors reported that after surface 
modification the fibers had excellent antimicrobial activity against Gram-negative Escherichia coli as well 
as Gram-positive Staphylococcus aureus. Therefore, these fibers might have a potential application on 
protective textiles, filters, and biomedical devices.  
In a similar study, Ma and co-workers (Ma et al., 2005), used poly(methacrylic acid) as graft 
polymerization, to modify the surface of the polyethylene terephthalate (PET). Firstly, they treated the PET 
fibers with formaldehyde to introduce the hydroxyl functional group. The oxidation of hydroxyl groups 
using Ce (IV) formed free radicals. The following step was the grafting of polymerization of methacrylic 
acid. Finally, by using a coupling agent, poly (methacrylic acid) grafted PET is grafted with gelatin. They 
could show that gelatin is covalently attached to poly (methacrylic acid) grafted on PET fibers. In Figure 
2-12, it is possible to observe the better endothelial cells (EC) growing on tissue culture plate (A), and 
better cell adhesion and proliferation in (C) than (B), due to the surface modification of the electrospun 
mats by grafting gelatin, and (D), the AFM images of the EC growing on the surface of the surface 
medicated mats. 
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Figure 2-12 (a) Endothelial cells (ECs) cultured in TCP, SEM image, (b) pure PET NFM, (c) gelatin- grafted PET NFM, (d) ECs 
on the gelatin modified PET NFM- AFM image. Source: (Ma et al., 2005) p. 2533. 
It was reported in another study (Song et al., 2013), that poly (lactic-co-glycolic acid) PLGA fibers could 
be reinforced by grafting small particles, by using poly (L- lactide) PLLA grafted on the surface of 
hydroxyapatite (HAP) nanoparticles for example. The presence of PLLA grafted on HAP increases the 
wettability of the fibers, and, at the same time, decrease the crystallinity of PLGA, consequently increasing 
the degradation rate. They reported that the bioactivity and the degradation of these composites fibers 
were dependent on the concentration of PLLA grafted HAP particles within the fibers. This surface 
modification was shown to promote greater cell adhesion and proliferation, once compared to the pure 
PLGA mats. 
2.2.5 Hydrophilicity  
One of the most influential parameters to control cell behavior via protein absorption is the wettability or 
surface hydrophilicity (Thevenot, Hu, & Tang, 2008). The most common method used to quantify the 
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wettability of a solid surface by a liquid is the water contact angle (WCA) measurement. This measurement 
is performed by a captive bubble or sessile drop technique in dynamic or static mode. Polini and Yang 
stated (Polini & Yang, 2017): 
“Contact angle is defined geometrically as the angle formed by a liquid at the three phase 
boundary where a liquid (L), gas (G), and solid (S) intersect. The interfacial tensions, γSG, 
γSL, and γLG, form the equilibrium contact angle of wetting (θ), which is described by 
the well-known Young equation”. See Figure 2-13. 
 
Figure 2-13 Young equation: γSG = γSL + γLG cos θ, where γSG is solid-gas surface tension, γSL solid-liquid surface tension, 
and γLG liquid-gas surface tension. Source: (Polini & Yang, 2017) p.107 
The measurement of the contact angle is the most accepted method used to determine the degree of 
hydrophilicity/hydrophobicity of the given surface (Pasricha & Sachdev, 2017). High contact angle values 
indicate that the liquid cannot spread on the surface well while low contact angle values show greater 
spreading. If the contact angle is greater than 90 degrees, the surface is said to be nonwetting with the 
liquid. On the other hand, when the contact angle is lower than 90 degrees, the liquid wets the surface, 
by doing so, the surface has hydrophilic behavior. Hence, it is important to note that nanofibers 
composites and nanofibers surface is not flat, the texture on the surface can include the surface 
roughness and air- trapped pores, these characteristics together can directly influence on the 
measurement of contact angle (Onda, Schibuichi, Satoh, & Tsujii, 1996). For this reason, the result 
obtained by the wettability assay of nanofibers must be interpreted with great care (Bico, Thiele, & Quéré, 
2002). 
In addition to the morphological attributes, another factor that may contribute to the hydrophobic/ 
hydrophilic behavior of the nanofibers is its chemical composition, the heterogeneities, and surface 
structure, in addition to other minor factors (Pasricha & Sachdev, 2017). When the nanofibers are used 
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as a matrix or as scaffolds, the wettability of the surface influences, directly the interaction between living 
tissue and synthetic surface.  
2.2.6 Mechanical Properties 
The mechanical properties of materials are crucial for either the optimization of tissue engineering 
scaffolds or to design medical devices. The development of nanofibers, depending upon their application, 
may be required different mechanical properties. In the literature is reported that the measurement of 
the mechanical properties of single nanofibers is still extremely challenging, due to the difficulty in 
manipulating and isolating the individual nanofibers and measuring the deformation and very small force 
involved (Polini & Yang, 2017).  
It is much easier to test the mechanical properties of bulk nanofibers composites of single nanofibers, 
due to the relatively large size involved. The mechanical properties of nanofibrous materials are strongly 
related to their fiber orientation and the porosity. A strong single nanofiber does not necessarily mean a 
strong nanofibrous membrane and vice versa. When measuring the mechanical properties of a nanofiber 
composite in membrane form, the specimens in dull-bell or rectangular shape are often used (Torres, 
Martinez & Lagaron, 2014; Yang et. al., 2009). 
2.2.6.1 Stress-Strain Curve 
Considered one of the most important tests to characterize the material’s mechanical property response 
the stress-strain curve as the tensile test6, which the specimen is clamped in a loading frame and 
subjected to a controlled displacement. Roylance stated (Roylance, 2001): 
“As strain is increased, many materials eventually deviate from this linear proportionality, 
the point of departure being termed the proportional limit. This nonlinearity is usually 
associated with stress-induced “plastic” flow in the specimen. Here the material is 
undergoing a rearrangement of its internal molecular or microscopic structure, in which 
atoms are being moved to new equilibrium positions. This plasticity requires a 
mechanism for molecular mobility, which in crystalline materials can arise from 
                                                        
6 Stress- strain testing is detailed by standards- setting organizations as American Society for Testing Materials (ASTM).  
Tensile testing of composite materials is prescribed in ASTM D3039.  
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dislocation motion… Materials lacking this mobility, for instance by having internal 
microstructures that block dislocation motion, are usually brittle rather than ductile”. 
When undergoing the tensile testing of the electrospun, it is obtained the stress-strain curve, which 
reaches the maximum stress right before the breaking point. In one study reported by Xu and colleagues 
(Xu et al., 2016), it was developed electrospun poly (ɛ-caprolactone)-pluronic- poly (ɛ-caprolactone)- based 
polyurethane nanofibers. In this study, they labeled the electrospun mates accordingly to the theoretical 
molecular weight of 3000, 6000, 8000, 10000, named PU3K, PU6K, PU8K, PU10K respectively. The 
fiber diameter obtained from the mats were, ~ 3.03 ± 0.99µm for PU3K, with the increase of molecular 
weight, the average diameter of the PU fibers significantly decreased. PU6K, PU8K, and PU10K had 
nanoscale fibers of 0.82 ± 0.36, 0.74± 0.19, and 0.71 ± 0.22 µm, respectively.  The mechanical 
properties of electrospun PU scaffolds with different molecular weight were measured by the tensile test. 
In Figure 2-14 shows the stress-strain curves of all samples, suggesting: 
“PU3K scaffold had the smallest tensile strength at 0.82 ± 0.18 MPa and elongation rate 
at 117.5 ± 9.7%. Simultaneously, PU3K had the lowest Young’s modulus of 0.78 ± 0.09 
MPa, indicating that the scaffold was the most pliable. Along with the increase in the 
molecular weight of PU, both the tensile strength and elongation rate improved. PU6K 
scaffold had a tensile strength of 1.16 ± 0.25 MPa and an elongation of 171.7 ± 13.5%. 
With a further increase in molecular weight, although the tensile strength increased from 
1.32 ± 0.30 MPa of PU8K to 1.63 ± 0.36 MPa of PU10K, the elongation rate suffered a 
loss, decreased from 165.5 ± 10.8% (PU8K) to 148.2 6 14.6% (PU10K). The Young’s 
modulus of the four specimens showed the same tendency as the tensile strength; the 
PU scaffold with the highest molecular weight had the largest Young’s modulus”. 
A detailed explanation of Tensile Strength (MPa), elongation at break which is given in %, and Young´s 
module will be better explained in the next section.  
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Figure 2-14 Strain–stress curves of the electrospun PU fibrous membranes, PU3K (a), PU6K (b), PU8K (c), and PU10K (d). 
Source: (Xu et al., 2016). 
2.2.6.2 Tensile Strength 
Polymers and polymer fibers consist of crystalline and amorphous domains. Under small tensile stress 
corresponding to the small strain polymer chain, found in the amorphous region, meant to be stretched 
(Sinha-Ray, Yarin, & Pourdeyhimi, 2014). The stretching force applied is followed by a response called 
entropic-response. Differently, as occurs in metals, in nanofibers mats even in the range of small stress 
and strains, when unloaded, as a result, occurs an irreversible strain, which remains (Khansari et. al., 
2012). It means that even though the mats undergo a strain of 5%, the fiber mats will begin to deviate 
from the linear elastic response. As the fiber mats continue, it increases the probability of failure of the 
fiber-fiber junctions and individual fibers. When this behavior happens, the strength deteriorates 
dramatically and catastrophic failure is observed, as we can see in Figure 2-14, data showing the 
breakpoint of the PU3K electrospun mats at 1.2. Taking the study done by Xu and colleagues reported 
in the previous section we have mechanical properties data shown in Table 2-3 for all the electrospun 
mats. The results reported by the authors suggested that the molecular weight of the PU copolymer 
significantly affect the mechanical properties of the PU nanofibrous mats. They also reported that the 
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higher molecular weight had the higher crystallization degree, so leading to a better mechanical strength, 
as we can observe in Table 2-3, the higher molecular weight of PU, results in a higher tensile strength. 
Table 2-3 Mechanical properties of electrospun PCFC- Based PU Fibrous Membrane. Source: (Xu et al., 2016). 
PU membranes Tensile Strength (MPa) Elongation at break (%) Young´s Modulus (MPa) 
PU3K 0.82 ±0.18 117.5 ± 9.7 0.78 ± 00.9 
PU6K 1.16 ± 0.25 171.7 ± 13.5 0.96 ± 0.11 
PU8K 1.32 ± 0.30 165.5 ± 10.8 1.15 ± 0.08 
PU10K 1.63 ± 0.36 148.2 ± 14.6 1.28 ± 0.18 
 
2.2.6.3 Young’s Modulus - Modulus of Elasticity  
Reported in the literature Young´s modulus is also called as modulus of elasticity, normally in a formula 
is referred as E, which basically, consist of the material property, describing its stiffness. Moreover, it is 
one of the most important properties of solid materials. 
When a mechanical deformation is applied to the materials, these materials have energy. The energy is 
dissipated plastically or stored elastically. The way that the material stores this energy are summarized 
in stress-strain curves as in Figure 2-14. Consequently, the stress is defined as force per unit area and 
strain as contraction or elongation per unit length (Institute, 2005).  
According to Hooke´s Law (the stress is directly proportional to the strain), we have the following equation 
(1): 																																							𝜎 = 𝐸	. 𝜀                                                                      (1) 
 
Where: 𝜎 is the stress [MPa] 
E is the modulus of elasticity [MPa] 
ɛ is the strain [ unitless or %] 
Therefore, from the Hooke´s Law the modulus of elasticity is defined as the ratio of the stress train:  																																									𝐸 = 	 '	(	                                                                         (2) 
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In 2009, in a study made by Zhang (S. Zhang, 2009), it was reported a comparison between the aligned 
and randomly nanofibers, the effects of polymer concentration on the crystallinity of electrospun 
nanofibers, and later, the effect of the fiber orientation and diameter on the mechanical properties. 
Regarding the degree of crystallinity of the fibers, increasing the polymer concentration and the feed rate 
of electrospinning process, it decreases the electrospun crystallinity. In the solutions with lower 
concentrations, there are fewer polymer chains, as a result, there are fewer chain entanglements, which 
helps the crystals to be formed. The lower polymer concentration, the higher the degree of crystallinity.  
The feed rate of electrospinning process can explain its correlation to the crystallinity degree. The 
complete cycle from the tip of the needle to the grounded collector is relatively long when the feed rate is 
lower. The crystallinity is increased, when the polymers can whip more completely comparing to higher 
concentration, thus they are stretched more than polymers with a higher feed rate. The alignment of the 
fibers does not change the crystallinity. Zhang stated:  
“The aligned fibrous mats processed much higher Young’s modulus and tensile strength 
than unaligned fibrous mats. This is due to that these two forms of electrospun nanofibers 
have characteristically different responses to strain resulting from two breaking 
mechanisms: the nonwoven mats were broken due to the failure of junctions and 
cohesion among the fibers at the bonding sites; however, the aligned nanofibers 
comprising the mat were oriented in the direction of stretching, thus mats were broken 
when the individual fibers were broken (…) The mechanical data also revealed that for 
aligned fibers as fiber diameter increases, Young’s modulus also increases. While 
theoretically Young’s modulus should be independent of fiber diameter. There are two 
reasons: firstly, to have the same cross-sectional area, the higher number of smaller 
fibers is required and this would increase the chance of fiber having defects which cause 
the fibers easier to be broken. Secondly, the alignment is not perfect. A higher number 
of smaller fibers has more chances to be unoriented with the direction of strain, thus 
they have lower Young’s modulus compared to larger fibers (…) higher degree of 
crystallinity leads to lower Young’s modulus for the aligned nanofibers. Because higher 
crystallinity means polymer chains are more oriented which results in the smaller 
diameter, as discussed above, with a smaller diameter, fibers have more chance to have 
defects, which makes them easier to break and the modulus was lost during crosshead 
displacement and results in lower modulus”.  (Zhang, 2009) 
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We can conclude that the statement made by Zhang, when he says, “While theoretically Young’s modulus 
should be independent on fiber diameter…”, once compared to Young´s modulus data from Table 2-3, 
is true, once that in the study made by Xu and coworkers, as they increase the molecular weight of the 
polymer solution, the diameter of the fibers was decreased, however, Young´s modulus was increased.  
2.2.6.4 Elongation Strength  
According to the IPC- TM- 650 Test Methods Manual (Circuits, 2006), the percent of elongation is 
calculated by dividing the elongation of the material at the moment of its rupture by the initial gauge 
length and multiplying by 100. When gauge marks are used to define a specific test section, only this 
length is used in the calculation. If the gauge is not used, then the distance between the grips is used as 
the initial gauge length. The result of elongation strength is always given in percentage as we can see in 
the following formula: 
    	𝑃𝑒𝑟𝑐𝑒𝑛𝑡	𝑒𝑙𝑜𝑛𝑔𝑎𝑡𝑖𝑜𝑛 = 	 (56789:;<78	:;	=>?;>=5)	×BCC	(<8<;<:6	9:95	6589;D)                         (3) 
 
In Figure 2-15 is possible to observe the comparison between the strength applied to the material versus 
the elongation. Note that different types of materials have different rupture point. According to the image 
is possible to observe that composites and polymers can undergo from middle to strong strength 
application and are ductile regarding their elongation. The elongation measures the percentage change 
in length before the fracture, as per se, the elongation to fracture is a measure of ductility. 
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Figure 2-15 Stress versus elongation for different materials such as composites, polymers, rubbers, foam, porous ceramics, 
glasses, metals and alloys, and, wood and wood products. Source: (“Strength ­ Elongation,” 2015). 
2.2.7 Porous Structure 
In nanofibrous materials employed as drug delivery systems and tissue engineering scaffolds, the pore 
structure of these materials is crucial. Generally, the pores of nanofibrous materials are formed by the 
intersection of nanofiber, it has been reported in the literature that some surface of single nanofiber itself 
may also possess porosity (Zhou et al., 2015). The most common techniques to evaluate the pore include 
mercury intrusion, BET (gas absorption- Brunauer- Emmett- Teller method) and gravimetrical method, 
although the most used technique to characterize the porous nanofibrous membranes are pore size 
distribution, specific surface area, average pore size and porosity (Polini & Yang, 2017). 
Mercury intrusion porosimetry is used to characterize the porosity- related characteristics materials. The 
first step consists in weighting the specimens, then the specimens are placed into the chamber which 
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will further have the void space filled with mercury.  An external force should be applied in order to make 
the mercury to penetrate the pores, once that mercury is a nonwetting agent for most of the substances. 
The Wasburn equation (Zhou et al., 2015) give us the pore diameter, where the required equilibrate 
pressure is inversely proportional to the range of the pore diameters, and to the size of the pores. The 
technique of mercury intrusion porosimetry may deform most of the electrospun materials, due to high-
pressure application required, which may lead to an underestimation of porosity, the smaller the pore 
size the higher compression pressure application required. For this reason, this method is more used to 
measure pores down to a few microns.   
             𝑑? = 	FGHI7JKL                                                   (4) 
Where: 𝑑? is the pore diameter 𝛾 is the surface tension of mercury 𝜃 is the angle between mercury and the sample 𝑃 is the pressure. 
BET is mostly used to characterize the porous structure by physical absorption of a gas (e.g., nitrogen) in 
the specific surface area of specimens then calculating the amount of gas absorbed to a monomolecular 
layer on the surface of the nanofibrous material (Khajavi & Abbasipour, 2012). The BET technique is 
combined, in most of the cases, with Barrett- Joyner- Halenda (BJH) analysis, aiming the determination 
of the pore distribution.  
Gravimetric measurements, the mass and the volume of the sample are first measured to determine the 
apparent density ρap (Pham, Sharma, & Mikos, 2006). Then according to the equation, the porosity is 
calculated: 
                    𝑃𝑜𝑟𝑜𝑠𝑖𝑡𝑦 = 	 Q1 − T:?TUV × 	100%                                (5) 
 
Where: 
ρap is the apparent density 
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ρm is the density of the bulk material 
Some composites materials are based the ρm on their respective densities and the weight ratio of the 
components (Zhou et al., 2015). Even though the gravimetric measurement is a convenient technique 
for porosity measurement, it is not applicable to the measurement of a specific surface area nor pore 
size (Polini & Yang, 2017). 
2.2.8 Morphology 
The characterization of electrospun are the major features of the fiber morphology, including alignment, 
shape (straight or curved; the round of flat), diameter and uniformity (uniform or beaded fibers). 
To observe a thin layer of nanofibers or nanofibers composites, usually, the fastest way to screen the 
morphology of prepared electrospun nanofibers is through the optical or light microscope. However, the 
most used technique used for morphological characterization of nanofibers composite is SEM, once that 
light microscope cannot achieve the level of resolution and magnification as an electron microscope can. 
Normally the typical resolution of the light microscope is about 200nm (Polini & Yang, 2017). 
The SEM microscope uses electrons beams instead of light to produce images of a sample. By doing so, 
the SEM has a significant potential to provide images with high quality with a resolution less than 1nm, 
once that the electrons have the wavelength much smaller than visible light. One of the great features of 
using SEM microscope is the possibility of revealing the three-dimensional shape of nanofibers because 
it has good depth of field thanks to the small aperture and large working distance. In this type of 
microscope, the sample is scanned by focusing the beam of electrons, the interaction by electrons and 
the sample, produces various signals at the sample surface, enabling the capture of these signals, 
revealing important information about chemical composition, surface topography, and morphology. The 
most useful signals detected by SEM apparatus are secondary electron (SE) and backscattered (BSE), 
they can be described as (Zhang et al., 2012) : 
• Secondary electron (SE): is dominated by edge effect, where the SE at the edge of the samples 
can leave the sample more easily than the internal areas; 
• Backscattered (BSE): this is a useful tool for revealing the differences in chemical composition of 
nanofibers composites. The BSE can have more production, when analyzing atoms with a greater 
atomic number, having a higher probability of producing an elastic collision due to their greater 
cross-section area. 
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2.2.9 FDA Approved Composites 
The U.S. Food & Drug Administration (FDA), is an agency within the Department of Health and Human 
Services.  
“The FDA's organization consists of the Office of the Commissioner and four directorates 
overseeing the core functions of the agency: Medical Products and Tobacco, Foods, 
Global Regulatory Operations and Policy, and Operations”          
(F. Organization, 2017). 
The FDA is responsible to validate and characterize either the drug is safe and can be used for any 
medical device or biomedical applications. The biomaterials are defined as any natural or synthetic 
substance engineered to interact with biological systems to direct medical treatment. 
All biomaterials must be biocompatible, meaning that they should perform their function with desirable 
and appropriate host response. When designing a biodegradable biomaterial, it is necessary to take into 
consideration some important features such as (Ulery, Nair, & Laurencin, 2011): 
1. Possess degradation time compatible with their function; 
2. Do not cause sustained inflammatory response or cytotoxicity to the living tissue; 
3. Produce nontoxic degradation effect that can be readily either resorbed or excreted; 
4. Include appropriate permeability and processability for the designed application; 
5. Have appropriate mechanical properties for their application. 
Polymers have been used in the last few decades by the scientific community, to achieve a better 
development of efficient drugs, targeting the need and minimizing the side effects. They have a significant 
potential due to the flexibility in chemistry gives rise to materials with a great diversity of mechanical and 
physical properties. The polymers with greater degradation, have more attention on the process of 
developing new drugs and medical devices once that they are able to excrete, breakdown or be resorbed 
without the need of invasive approaches such as surgical intervention or removal.   
Among all applications of biomaterials made from composites, we can distinguish the drug delivery 
devices and tissue engineering. The host response of these composites biomaterials may vary according 
to the physical, biological and chemical properties of the biomaterials. It is important to note that when 
these materials are at the same time biodegradable, there will be always an additional issue regarding 
this matter, which consist on the continued changes in the material properties induced by degradation 
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over the time. The degradation of these materials may lead to a long-term host response, differently than 
the initial response. These issues have contributed to the evolution, of biodegradable polymeric as a field 
of research. 
The development of new composite materials, application of polymers for drug delivery systems, as well, 
for the development of new biomaterials have been growing thanks to the efforts done by researchers 
worldly wide, combining different expertise in materials, biology, chemistry, engineering and chemical 
practices (Ulery et al., 2011).  
2.2.9.1 Polycaprolactone (PCL) 
Poly(ɛ-caprolactone), also known as (PCL), is a biodegradable and biocompatible polymer (Gazzarri et al., 
2013), which has slow degradation rate and excellent mechanical properties (Luong-Van et. al. 2007; 
Merrell et al., 2009; Selcan et. al., 2014). Since the 1970s, it has been approved by US Food and Drug 
Administration (FDA) as a safe component in implants. Thereafter, is has been frequently used in 
biomedical applications. PCL has been used in a variety of application, such as bone tissue engineering, 
packaging materials and implantable biomaterials due to its slow degradation nature (Luong-Van et al., 
2007; Sheikh et al., 2014).  
The application of PCL in tissue engineering application may have some limitation, once the polymer 
possesses poor cell affinity due to its hydrophobic nature. Plasma treatment can overcome this limitation 
and improve the hydrophilic effect of the material (Shin et al., 2010). The high molecular weight PCL 
impart high elasticity and tensile strength, making it attractive in the manufacture of bone, cartilage, 
suture, tendons and other medical applications, where mechanical strength is a major requirement. When 
dealing with electrospun technique, PCL has some disadvantages as lack of cell adhesion, intrinsic 
hydrophobicity, and absence of biological recognition site (Sheikh et al., 2014).  
Among the variety of biomaterials that have been investigated over the last few years for tissue 
engineering, drug delivery systems and skin grafts, electrospun nanofibers with high porosity and high 
surface-to-volume ration can increase the efficiency of cell attachment, it has attracted the great interest 
of PCL use for the biomedical application. In addition to that, the loading capacity of nanofibers can be 
increased by the porous structure, becoming a great candidate for immobilization of biomolecules (Polat 
et. al., 2015). The latter may be remedied through internal modification of PCL nanofibers to counteract 
hydrophobicity, to incorporate hydrophilic constituents, and to enhance biocompatibility. Some attempts 
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have been made to approach this strategy include blending PCL with some natural bioactive polymers, 
such as gelatin, chitosan, collagen, cellulose, lecithin were used as an alternative to improve interaction 
between PCL scaffolds surface and cultured cells (da Silva et al., 2009; Zhang et al., 2012; Zhang et. al., 
2005; Zoppe, Peresin et. al., 2009). Also, chemical modification of PCL nanofibers by grafting with 
hydrophilic dextran, polyethyleneimine, cellulose nanocrystals and poly(ethylene glycol) has been 
performed to improve cell proliferation and cell spreading on the surface of the electrospun mats (Ji & 
Hyuk, 2007; Kim et al., 2009; Zoppe et al., 2009) 
2.2.9.2 Linear (LPEI) and Branched (BPEI) Polyethylenimine 
It is known that cancer cell lysosomes may play an important role in intrinsic multidrug resistance (MDR), 
which is an important hindrance to effective cancer therapy by accumulating chemotherapy drugs and 
deactivating their therapeutic action. The polymer studied in this manuscript, the cationic charged organic 
macromolecule which contains amino nitrogen as every third atom, polyethyleneimine (PEI), can disrupt 
the lysosomal/endosomal membrane via proton-sponge effect (PSE) to provide an effective buffering 
system for the sudden decrease in pH from the extracellular environment to the endolysosomal 
compartment (Huh et al., 2007; Zhou, Murdoch, & Shen, 2015). Therefore (PEI) has been used to 
transfect a variety of cell types, both in vitro and in vivo (Reed et. al., 2006). PEI is available in both 
branched (BPEI) and linear forms (LPEI), they belong to the class of synthetic cationic polymer with 
excellent transfection efficiency with antiviral properties and gene delivery (Fox et al., 2016; Parhamifar 
et. al., 2010; Spoden et al., 2012).  
A number of quaternized derivatives of PEIs, either in form of coatings or nanoparticles have shown to 
elicit potent antimicrobial activity against Gram-negative and Gram-positive pathogens. However, there 
exist only a limited number of studies that have evaluated the cytotoxicity of PEIs for melanoma cells. 
Linear or branched PEIs cytotoxicity is directly related to the polymer molecular weight and exposure 
time. The use of PEIs for biomedical applications is attractive because PEI-coated medical devices are 
under medical trials for extracorporeal blood purification therapies and PEI-based hydrogels have been 
approved by the US Food and Drug Administration (FDA) (Fox et al., 2016).  
Scientists have done several approaches for melanoma cancer treatment and gene therapy including 
both PEI polymers, either Linear or branched (Ogris et al., 2003), given by their attractive properties for 
drugs delivery systems (Seong-Cheol et. al., 2013). PEIs are promising synthetic vector for drug or gene 
delivery due to its high cationicity, allowing it to protect and condense small interfering RNA or nucleic 
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acids (plasmid DNA), enabling proton sponge effect by endosomal escape and well nuclease digestion 
(Benjaminsen et. al., 2013). The kinetics of cells association of both, is very important, once that there 
is the substantial internalization of PEI bound to the plasma membrane of malignancy cells. However, 
some non-specific binding could be expected due to the ionic interaction, the polycations interactions with 
the components of the cellular membranes, may regulate their cellular uptake route (Seib, Jones, & 
Duncan, 2007). The toxicities and transfection efficiencies of PEIs differ in structure dependent or mass 
dependent manner, so far it is very difficult to have any defined relationship between these parameters 
(Han et. al., 2014; Kwok & Hart, 2011). The use of PEIs might be limited by its proinflammatory effects 
and high toxicity effects (Kawakami et. al., 2006). 
2.3 Biomedical Applications of Nanofibers Composites 
2.3.1 Drugs Delivery Systems 
Recent advantages in the nanotechnology field have enabled the development of new alternatives to 
approach the treatment of several skin diseases, this approach aims to design a more efficient and 
controlled drug delivery systems, and at the same time minimize the side- effects of the traditional drugs, 
in which more often are administrated orally or through intravenous pathway. Drugs designed to deliver 
active compounds are thought to not interfere directly with the metabolism of the patients, therefore, they 
are a less invasive than traditional approaches (Naves et al., 2017c). Nanotechnology refers to the 
fabrication, characterization, and applications of active substances for various use (Sridhar et al., 2015).  
When designing a new drug delivery system (DDS) it is very important to take into consideration some 
major primary criteria such as the therapeutic window and the desired drug dosage. Drugs delivery 
nanocarriers are possible by employing based nanomaterials. With nanotechnology and the use of 
nanomaterials together, it becomes possible to encapsulate a variety of important therapeutic agents, 
such as peptide protein-based drugs, nucleic acid, and small molecules either hydrophilic or hydrophobic, 
minimizing the toxicity in healthy cells and at the same time helping to enhance the therapeutic 
bioavailability at the target area. By encapsulating different chemicals and molecules into the nanocarriers 
it is possible to monitor the solubility and the stability of drugs (Langer, 1998).  Biological nanomaterials 
are preferable when possessing some important characteristics such as biodegradable, non- toxic, 
biocompatible, chemical compatibility with physiological solutions, preferably the use of biological/natural 
materials, easy to modify and design (Korrapati et al., 2015).   
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Many functions in the skin are performed by the stratum corneum. It plays a major role in the regulation 
of the transport of different chemicals compounds into the skin. Therefore, the skin is the largest organ 
in our body that can be approached to delivery active compounds or different drugs by transdermal or 
topical route. Passive and active skin penetration has been achieved and improved the efficiency of either 
topical delivery (the drug is delivered to the skin strata) or transdermal delivery (the drug is delivered into 
subcutaneous tissue, and later, taken up systemically into the body. The new topical therapies have 
gained over the last few decades a huge interest of the scientific community, once that it can be used as 
a tool to treat several types of skin disorder as psoriasis, contact dermatitis, and skin cancer which is the 
aim of this Ph.D. thesis. These drugs are delivered directly into skin strata (Zheng et. al., 2014). Over 
other delivery routes topical and transdermal systems ensure additional vantages, among all, we can 
distinguish: maintain the therapeutic effect of the drug at a lower dosage, enhance the biocompatibility 
by evading the hepatic first-pass metabolism, and bioavailability of the therapeutic agent at the target 
cells or tissue. The point of prime concern is the drug penetration while adopting the transdermal drug 
delivery route. It has been reported, in this context, that nanoparticles can enhance the drug penetration 
efficiency across the mucous membrane and the skin barrier (Zheng et al., 2012). 
In 2017, Naves and co-workers stated (Naves et al., 2017c): 
“Transdermal drug delivery system is an important route to deliver drugs into the body; 
the delivery through this approach is focusing in many alternatives to overcome some 
crucial problems related to the protective barrier of the skin. This approach may offer 
several advantages; since the skin is the biggest organ in the human body, it represents 
a relatively and readily accessible surface area for drugs absorption. The delivery of 
medication through transdermal route is less invasive when compared to other 
approaches, such as intravenous and oral route; this last approach can lead to drug 
degradation under extreme acidity of the stomach, and might interact with food, causing 
erratic delivery”. 
In addition to the above statement, we can also mention that transdermal route allows ceasing the 
compounds or the absorption of the drug, preventing undesired effects and in the worst scenario drug 
overdose (Contreras, 2007). However, this method also presents some disadvantages, once that not all 
compounds available are suitable as nanocarriers to overcome the skin barrier. 
UNIVERSIDADE DO MINHO 2C2T- Centre for Textile Science and Technology  
Doctoral Thesis 
 
 60 
Without the need of frequent dressing changes and sustainable fashion over a longer period, controlled 
drugs delivery system (DDS) can provide an excellent delivering of drugs to the wound sites, reducing the 
patient exposure to an excess of drugs beyond the dosage which is required for wound healing, and even 
skin tissue engineering. Drugs delivery systems are potentially useful in the treatment of local infections 
where it might be beneficial to avoid high systemic doses while increasing local delivery concentration of 
antibiotics, it is possible to release active substances to the wound sites in a controlled way for sustained 
period, about a week or more, it could be made by bioadhesive, naturally, synthetic and semi-synthetic 
derived from polymeric dressing (Lee & Park, 2000).  
When dealing with patient compliance, DDS have advantages, especially in the treatment of chronic 
wound management, where most of the patients undergo for a long treatment period. In addition to that, 
these systems are biodegradable and therefore can be easily washed off the wound surface, after they 
exerted their proposed effect (Rao & Devi, 1988). 
Nowadays, most of the modern wound dressing are made from polymers which can play a role in the 
release and delivery drugs to the wound sites. Biodegradable polymeric microencapsulate dressings have 
received great attention as a potential drug delivery vehicle in consideration of their applications in target 
drug delivery, once that they are employed for controlled drug delivery to wounds include. The modern 
wound dressing can be classified as hydrogel dressing, hydrocolloid dressing, semi-permeable adhesive 
film dressing, biological dressing and foam dressing (Burrell & Morris, 1998; Ishihara et. al., 2006; Katti 
et. al., 2004; Maeda et. al., 2001). 
In the 21st century, drugs microencapsulation technology has been applied for drugs delivery. It possesses 
a significant potential for therapeutic and pharmaceutical fields, as it provides controlled and sustained 
release of pharmaceutical agents for various medical proposes. It is necessary to have some technical 
consideration regarding the futures and requirements of microencapsulated pharmaceutical agents; 
these agents must be identified and specified before the drug design. Ethical approval of pharmaceutical 
products should be obtained to demonstrate the use of the drugs, as being supported by results of clinical 
trials and animal’s experiments. Lucas et. al. (Naves et. al., 2016), mentioned that according to the EU 
7th amendment of the Cosmetic Directive, the studies in vivo should only be performed when it is not 
possible to achieve reliable and better scientific outputs in vitro, therefore, in vivo studies should be 
replaced for in vitro models and procedures. Economic, quality and the technical issue should be 
considered when the pharmaceutical agents microencapsulated technology is employed for the mass 
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production. When these drugs are designed for the therapeutic application, is very important to identify 
and examine carefully the chemical, physical and therapeutic properties of microcapsules (Naves et al., 
2016). To avoid an overdose administration of a drug, the drug entrapment amount in microcapsules 
should be cautiously controlled. In addition to that, the particle size of microcapsules designed could alter 
the total surface area for the drug release. The quality control is necessary for producing 
microencapsulated medicine with an acceptable quality (Orive et. al., 2004). 
Microencapsulation technology may provide many benefits in transdermal drug delivery. 
Microencapsulation provides a physical barrier to protect the drugs which are liable to external 
environments such as evaporation, heat, alkalinity, acidity, oxidation or moisture before releasing the 
drugs in order to improve its stability. It also improves the drawbacks of conventional drugs delivery 
routes, including poor compatibility and bioavailability, short life and absorption. When thought in a 
specific therapeutic purpose the long-term therapeutic performance could be enhanced by 
microencapsulating drugs with an appropriate host response, the drugs can be released at once or 
moderately and gradually (Bansode et. al., 2010). All the materials employed on the development of the 
microcapsules formation should be standardized in terms of purification, reaction situations and chemical 
compositions to achieve the efficiency and biosafety requirements and minimize the variability production 
in different laboratories (Orive et. al.2003). 
In 2013, Lam and Gambari stated (Lam & Gambari, 2013):  
“Transdermal delivery is to apply the medicine drug to the skin, the drawbacks of oral 
administration such as enzymatic degradation and rapid clearance in the gastrointestinal 
tracts or the first pass metabolism therefore can be avoided. Drug delivery target the skin 
sited alleviates the physical pain and discomfort and promotes the patient convenience 
and compliance for drugs treatment. Although the skin offers a relatively large and readily 
accessible surface area for drugs absorption, the skin target drugs delivery still present 
limitation. The human skin is an impermeable barrier that provides a strong protection 
against external substances… Skin is mainly composed of two layers: the underlying layer 
and upper basement layer. In the underlying layer, various types of cells, blood vessels, 
lymphatics, and nerves are found as a dense network of connective tissue. In the upper 
basement membrane, more than 90% of stratified keratinocytes exist, and keratinocytes 
undergo the cell differentiation and move upwards from the stratum basale, through the 
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stratum spinosum and stratum granulosum, to the outermost layer, the stratum corneum 
to finally become corneocytes… The stratum corneum, as an outermost layer of the 
epidermis, provides an extremely effective barrier for the control of drug penetration by 
an incapability of large majority of drugs to pass the skin at therapeutic rates whereas it 
is also the main barrier to spread the water out of the skin… Therefore, the major 
challenges of transdermal drugs delivery are to overcome the strong barrier function of 
the skin as this barrier lead to slow drugs penetration rates, limited drugs uptake rate, 
lack of dosage flexibility or precision.”  
Drugs topical delivery is related to the application of drugs to the skin surface, aiming to delivery 
therapeutic agents through skin into the systemic circulation or bloodstream (transdermal delivery) or to 
pathological sites of the skin (dermal delivery) (Garvie, 2016). As an example of skin disorder treated 
using transdermal delivery we can mention severe pain which is treated with fentanyl (Delgado & Guy, 
2014), while eczema and psoriasis are treated using dermal delivery (Flowers, 2004). The efficacy of 
topical drugs delivery is directly related to the diffusion of the therapeutic agent through the skin and the 
drug formulation. 
When compared to intravenous and oral delivery, the administration of drugs by dermal and transdermal 
routes are advantageous in several aspects. Once that the formulation is applied directly to the affected 
site of the skin, it is possible to minimize or even eliminate any adverse side effect which may occur for 
the oral treatment of skin disease, as a lower dose is needed. Oral treatment requires higher systemic 
concentration of the drugs to achieve the therapeutic effect at the disease site. The concentration of the 
dose, once that passes through the metabolism, in case of oral administration, involves a peal of drug 
concentration in tissue, organs, and blood, this is followed by a decline. Transdermal or dermal delivery, 
allow lower daily dose.  
In addition to that, it can maintain the drug level with the therapeutic windows for prolonged time, reducing 
the frequency of dosing required and extending the duration of the action of the drug. When using a patch 
or scaffold as we propose in this study, the input can be determinate simply by its removal (Garvie, 2016). 
In Figure 2-16 we can obverse several biomedical applications of nanofibers composites. 
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Figure 2-16 Biological application of nanofibers composites. Source: (Ramalingam & Ramakrishna, 2017), p11. 
2.3.2 Permeation Pathways 
The drugs penetration rate can vary from one skin type to the other, depending directly upon the 
application site, the type of skin disease under treatment, age, race, etc. An ideally transdermal DDS 
should allow a considerable amount of drugs to overcome the skin barrier, providing adequate release of 
the drug formulation. The patient’s health condition can be worsening if the development of the drug is 
not biocompatible, leading to skin irritation and cytotoxicity of healthy cells. Some researchers have 
reported the enhanced cell proliferation of human dermal fibroblast (HDF), by using biocompatible 
polymers on formulation and development of nanofibrous wound dressing for skin tissue engineering (Jin 
et al., 2013).  
The permeation of drugs through (trans) dermal route is possible to be achieved by three main pathways, 
in which the drugs can penetrate the stratum corneum, these routes are namely: intercellular domains 
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(intracellular), cells themselves (transcellular) and via appendages (appendageal) Figure 2-17. The 
percutaneous absorption of active compounds topically applied is directly related to the density of 
appendages such as sweat glands and hair follicles Figure 2-18, nature of permeating molecules. 
Depending upon the route of drugs delivery is possible to delivery either to the skin surface or into 
systemic blood circulation, at the site of application. 
The intercellular is believed to be made by uncharged molecules, in which the major pathway for the 
permeation is small (< 500g mol-1) (Bos & Meinardi, 2000). The compound permeation in this route 
occurs by diffusion across lipid lamellae. Providing the limiting step rate, which these intercellular lipids 
contribute to the continuous phase within the stratum corneum, from lamellar structures between the 
corneocytes. 
The transcellular is a route that needs repeated penetration of the permeating compounds into and out 
the intercellular lipids and the corneocytes. In this route, the compounds at the SC must diffuse through 
both hydrophilic regions, which is hydrated keratin within corneocytes and the lipophilic regions, the lipids 
(Garvie, 2016) 
The appendages can penetrate the epidermis and the stratum corneum, which can provide a route known 
as bypass barrier. This route can vary the density of the appendages, consistently low related to the 
anatomical site. This low resistance route can play an important role in ionophores, important for low SC 
diffusivity, such as a large molecular weight of active and hydrophilic compounds. 
 
 
Figure 2-17 Percutaneous absorption of drugs topical application, namely transcellular and intercellular routes. Source: 
(Garvie, p6, 2016). 
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Figure 2-18 Images showing skin surface and saturated absorption of isothiocyanate followed by 30 min (a), 1 h (b), and 2 h 
(c). Possible nanoparticle route through a follicular pathway. (Alvarez et. al., 2004). With permission from Elsevier. 
2.3.3 Implications of Nanofibers Based in DDS in Healthcare 
Extracellular matrix (ECM) based on nanofibers, imitated their surface functionalization capabilities and 
the inter-connected fibrous morphology, so for these reasons the composite nanofibers can offer a 
potential platform to immobilize/incorporate therapeutic agents to develop and provide local drugs 
delivery systems (DDS), owing to their nanoporosity and high surface area (Hu et al., 2014). Acting as 
efficient carriers for the pharmaceuticals, genes and growth factors, the nanofibers-based DDS ensure its 
application in various medical fields including tissue engineering, advanced pharmaceuticals, surgical 
implants, cancer therapeutics, wound dressings, etc. (Kanani & Bahrami, 2010). Synthetic and natural 
polymers for scaffold design can be employed for drug functionalization, encapsulation or crosslink 
strategies. The polymers applied are directly dependent upon the therapeutic requirement such as the 
mode of drug release (biphasic/triphasic/pulsatile/immediate) and drug release kinetics 
(delayed/burst/slow). Figure 2-19, allows us to see different nanofiber composite design explored as 
DDS, thus electrospinning technique a variety of nanocomposites morphologies and structural flexibility 
can be fabricated, e.g., layered nanocomposites, hybrid composites and core-shell nanocomposites 
structures, which will later control the drug release profile of the proposed therapeutic agent.  
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Figure 2-19 Composite nanostructures used as DDS. Source: (Dhand et. al. 2017, p.201). 
For wound dressing application, with their ability to mimic the functional and structural biology of ECM, 
nanofibrous meshes may help to promote the hemostasis of injured tissue, allow cell respiration (due to 
high porosity) and absorbing wound exudate thanks to its high surface area. In addition to that, the nano 
dimension pores size, they prevent infiltration of external microorganism at the wound area, in this 
manner it can discourage cell/tissue infiltration. Active wound dressing nanofibers can be designed by 
incorporating growth factors, antimicrobial ingredients (Aloe vera, honey), antimicrobial metals ions (Cd2+, 
Ag+, Cu2+, etc.). For tissue engineering applications, the nanofibrous scaffolds provide ECM- mimetic 
physical support which is very similar to the fibrous proteins of native ECM, leading to better regeneration 
and growth of the tissue. It is possible to open new avenues for designing organ remodeling, site-specific 
DDS, and artificial organ implants by incorporating therapeutic genes, antibiotics, growth factors, etc. All 
these properties together provide nanofibrous scaffolds many benefits towards healthcare application and 
use (Abrogo, McArthur, & Kingshott, 2014; Rujitanaroj, Pimpha, & Supaphol, 2008). 
2.3.4 Wound Healing  
Wound healing is a dynamic and complex process by which the body tissue or even the skin repairs itself 
after injury. When dealing with chronic wounds there is a need for the development of new wound healing 
products, focusing proper functioning of human organ system and faster healing of wounds. Before 
choosing a wound dressing some factor should be considered, as the size of the wound, volume of 
exudate, health of the patient, type of the wound, the presence of infection, physicochemical properties 
of the wound dressing (Dhand et. al., 2017). Electrospun mats have shown among many options great 
promise for formulating wound healing products, known as a wound dressing, it is pharmaceutical 
compress or sterile pad which is applied in contact to the wound to stimulate or assist the healing process 
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and prevent the wound from any form of infection. The mats can be used as wound dressing to accelerate 
the wound healing process, however, if not managed effectively in timely manner and application the 
wound can directly interfere with the patient wellbeing.  
There are some characteristics ideal for wound healing which include absorption of wound exudates, 
bacterial barrier, moisture maintenance, ease of removal, hemostatic efficiency, space for gas exchange 
and low cost. To prevent microbial infection at the wound site, one of the most common approaches 
includes the blending of polymers with antibacterial nanoparticles, this may act synergistically (Ebrahimi 
et al., 2016). Researchers have been investigating the various combination of biocompatible electrospun 
mats with different nanoparticles grafted for speeding up the healing process. For instance, Ebrahimi- 
Hosseinzadeh and colleagues reported the in vivo results showing the efficacy comparison of the 
commercially available ChitoHeal Gel and gelatin/hyaluronic acid (GE/HA) electrospun mats with 
diameter range size of 20 to 150 nm (Ebrahimi et al., 2016). The results, see Figure 2-20, of this study, 
showed an improvement of wound closure percentage for ChitoHeal gels and GE/HA nanofiber composite 
of 77.8% and 81.9% respectively, untreated control group show 65% of wound closure. It was 
demonstrated that the dermal defect recovered back to its normal condition within 14 days postoperation. 
The histological results confirmed lesser inflammatory cells and increased epidermis production in 
ChitoHeal gel and GE/HA treated group compared to the control.     
 
Figure 2-20 (A) Macroscopic appearance of skin wounds treated with gauze as control, ChitoHeal gel (containing chitosan) 
and GE/HA nanofibrous at day 1, 7 and 14 in excision wound model. (B) The assessment of burn wound healing. (C) Wound 
contraction ratio of the wound treated with control, ChitoHeal gel and GE/HA nanofibrous membrane. Source: adapted from 
(Ebrahimi et al., 2016). 
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2.3.5 Cancer Therapy 
Cancer is one of the deadliest diseases, showing continuously increased incidence and mortality rates 
worldwide (Chen et al., 2015). Cancer treatment remains a challenging task, especially when dealing 
with prevention or completely eradication of cancer cells without damaging the rest of the body.  It is well 
known that for cancer treatment are commonly used traditional therapies such as chemotherapy or 
radiotherapy. Chemotherapy is the most engaged treatment, using anticancer drugs, which often fails 
because of the highly toxic effects of the chemotherapeutic drugs, reported to have enormous side effects 
to the patients. The main cause for the failure to account for the discrepancies encompassing cancer 
therapies are inadequacies in the administration of therapeutic agents, with uncontrollable and lack of 
selective features. In the last few decades, researchers are focusing their research, to minimize the side 
effect in the other body sites of the patient and increase the therapeutic effect to the carcinogenic target 
tissue. These efforts are thanks to the development of smart drugs delivery systems, possibly due to the 
development of nanotechnology, exploring potential new nanomaterials, including polymeric micelles, 
polymeric nanoparticles, DDS for cancer therapeutics, dendrimers structures, liposomes, carbon 
nanostructures (CNT, fullerene), etc. Due to dedicated and consistent research efforts, many of these 
approaches have been approved for clinical trial and are nowadays commercialized in the market (Dhand 
et. al., 2017). 
Recently, drug-loaded composite nanofibers have attracted enormous attention from the scientific 
community for use in controlled and local drug delivery in cancer therapy. Due to technological advances, 
nanofibers composites are emerging as an alternative strategy for cancer prevention and treatment. They 
possess the ability to mediate drug delivery with prolonged exposure of the drug to the carcinogenic cells, 
improving the targeting ability of the drugs, as well the solubility of water-insoluble drugs (Munaweera, 
2015).  Chen and co-workers (Chen et al., 2015) developed some multifunctional electrospinning 
composite fibers for orthotopic cancer treatment in vivo, which they stated: 
“DOX-loaded NaGdF4: Yb/Er@NaGdF4: Yb@mSiO2-polyethylene glycol nanoparticles were 
incorporated into PCL and gelatin loaded with antiphlogistic drug MC, to form 
MC/UCNPS/DOX CFs by electrospinning. The resultant multifunctional spinning pieces 
can be surgically implanted directly at the tumour site of mice as part of orthotopic 
chemotherapy by controlled-release DOX from mesoporous SiO2 and the upconversion 
fluorescence/magnetic resonance dual-model imaging through NaGdF4:Yb/ 
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Er@NaGdF4:Yb embedded in MC/UCNPS/DOX in vivo. Additionally, MC in MC/ 
UCNPS/DOX CFs suppressed the inflammatory response, which helped in wound 
healing in vivo. These results provide an encouraging prospect of using drug-loaded 
electrospun nanofibers in orthotopic diagnosis and treatment combined with current 
treatment protocols, especially for those patients suffering from unresectable tumours or 
metastases cancer.” 
 (Chen et al., 2015) 
In Table 2-4, we show some composite nanofiber system explored as DDS for cancer therapeutics. Drug-
loaded composite electrospun mats can release controlled drug by properly designed architecture, mode 
of drug incorporation, fiber diameter, the composition of nanofibers and porosity (Rujitanaroj et al., 2008).   
Table 2-4 Drugs delivery system based on electrospun nanofibers reported for cancer therapeutics. 
Polymer Additive/filler Anticancer drug  Reference 
PCL,Gelatin Unconventional core/shell Silica 
NPs 
Doxorubicin, 
indomethacin 
(Hou et al., 2013) 
PLLA Titanium in the form of Titanocene 
drug 
Titanocene (Ping Chen et al., 2010) 
Self- assembled Peptide Platinum drug Cisplatin; Cis-
dichlorodiammine 
platinum 
(J. Kim, Anderson, Jun, 
Repka, & Jo, 2009) 
PLGA CNT Doxorubicin (Yu, Kong, Li, Li, & Yan, 
2015) 
PLLA CNT Doxorubicin (Z. Zhang et al., 2015) 
PLA Platinum drug Cisplatin (P. Chen, Wu, Ding, & 
Zhu, 2011) 
PLLA Fullerene/C70 Paclitaxel (Liu, Wei, & Chen, 
2014) 
Abbreviations: PCL – polycaprolactone, PLLA - poly-L- lactic acid, PLGA - poly(lactic-co-glycolic acid), CNT - carbon nanotubes, PLA - poly- 
lactic acid.      
2.4 Biofunctionalization of Fibrous Scaffolds 
For the use of therapeutic and advanced biological application, it is essential that the surface of the 
electrospun mats are either incorporated or coated with bioactive molecules or bioactive agents. During 
the fabrication of tissue scaffolds, certain natural or synthetic polymers can be used, once they may have 
unique biological functions. Coating natural polymers on the surface of synthetic polymers fiber is one 
approach which can be used for biofunctionalization. As another alternative, it is possible to mention, 
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aiming to obtain drug release of fibrous scaffolds, the hydrophobic therapeutic drugs that can be directly 
blended into the electrospinning polymer solution (Baji & Mai, 2017). 
2.4.1 Interactive Characterization of Cells to Nanofibers  
When using biomedical application by developing nanofibers, it is crucial to determine the interaction cell 
to cell, and cell to the scaffold. This aims to evaluate the cell adhesion to the electrospun mats, the 
proliferation, tissue regeneration and the most important features which are the drug delivery profile and 
the cytocompatibility, that will be better explained in the following sections (Pasricha & Sachdev, 2017). 
2.4.2 Cytocompatibility  
Over the last few years, we have observed the increase of use of nanofibers in the field of pharmaceutical 
and biomedical studies. Thus, it has become significantly important their potential cytocompatibility, and 
the characterization of their effects after exposure to the biological system. Comprehensive study and 
detailed understanding of chemical-physics and nano-bio interactions of nanofibers are important to 
prevent the risk of materials failure at preclinical or late clinical stages. Studies such in vitro and in vivo 
are important assays to characterize the cytocompatibility of all electrospun nanofibers, either natural or 
synthetic polymers-based. These studies are important for skin, tissue and cell engineering applications. 
They also indicate that the cellular response depends on cell type, nature of scaffold and surrounding 
medium (Yoshimoto, Shin, Terai, & Vacanti, 2003). 
In vitro cytotoxicity has become an integral aspect of drugs discovery because it is cost-effective, predictive 
and convenient means of characterization the toxic potential of new chemicals entities. The observation 
of toxicity testing is critical and a necessary research and industry practice to define and identify the safety 
thresholds for new potential drugs for drugs delivery including chemotherapeutics. Niles and co-
colleagues state that: 
“The advent of in vitro cytotoxicity testing has greatly streamlined this process and is now considered to 
be a nearly compulsory activity starting at target validation and continuing through medicinal modification. 
Unlike animal-based toxicology testing, there are clearer definitions and greater agreement for what 
constitutes cytotoxicity in vitro.” (Niles, Moravec, & Riss, 2009)  
The cytotoxicity refers to a treatment or compound if it can prevent cellular attachment, leading to a 
reduction in overall viability, adversely affects replication rate or cause dramatic morphological changes. 
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It is important to note that the manifestation of these effects are directly related to the mechanism of 
cytotoxicity and length of exposure (Riss & Moravec, 2004).  
Both in vitro and in vivo, give us the important characterization of nanofiber, the cells response and sense 
to the physical properties of the electrospun mats matrix by covering mechanical cues into intracellular 
chemical signals, which in turn control phenotypic behavior, protein production and gene expression 
(Pasricha & Sachdev, 2017).  
2.4.3 Cytotoxic Assays  
The basis to understand and have a better insight regarding the reaction of the potential biomaterial when 
present in the body is through cell culture methods. Cells cytotoxicity assay, chemistries are formulated 
to detect loss of membrane integrity associated with cell death (Niles et al., 2009). It is called in vitro 
testing methods. In this type of testing model, there is a selection of a specific cell lineage to mimic a 
response likely sensitized or observed by biomaterials, scaffolds or particles in vitro.  In 2008, Williams 
suggested: 
“The biocompatibility of a long-term implantable medical device refers to the ability of 
the device to perform its intended function, with the desired degree of incorporation in 
the host, without eliciting any undesirable local or systemic effect in that host… The 
biocompatibility of a scaffold or matrix for tissue engineering products refers to the ability 
to perform as a substrate that will support the appropriate cellular activity including the 
facilitation of molecular and mechanical signaling systems, in order to optimize tissue 
regeneration, without eliciting any undesirable local or systemic responses in the eventual 
host.”  
(Williams, 2008) 
Currently, the most used cytotoxicity biomarkers are conserved, constitutive and relatively stable, high-
abundance enzymes “released” into the extracellular environment following the loss of membrane 
integrity. This extra-cellular environment is also called as culture medium. The detection of cytotoxic 
biomarker activities outside the membrane compartment after treatment is referred as proof-positive for 
compound´s cytotoxic effect. On the contrary, the viability assays, the decline in cell response is 
interpreted to be caused by cell death or cell-cycle arrest. It is important to note that enzymatic decay as 
a function of time in the culture medium can lead to underestimation of the absolute level of cytotoxicity. 
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Activity-based surrogates of cell death, can have their utility limited, due to a finite enzymatic half-life 
during long compound/cell contact incubation (48-72 hr) (Niles et al., 2009). When performing in vitro 
tests, it is crucial to observe if there is no false positive or false negative outputs from the study. This may 
happen due to the fact that most of the cells cultures are very sensitive to changes in their environment 
and experimental condition, such as, necessity of proper UV sterilization of the fume hood which may 
lead to cross-contamination, pH of the medium, lack of antibiotics into the medium, chamber temperature 
and O2, incubation time, medium changes, following the protocols (Goonoo, Bhaw & Jhurry, 2014a). 
Therefore, it is crucial to control the experimental conditions to ensure that the measured cells death 
does not correspond to the toxicity of the added electrospun mats but instead as a result of unstable 
culturing conditions (Pasricha & Sachdev, 2017).  
BSI, ASTM, and ISO are some standard protocols used for cell culture assays, to evaluate the 
biocompatibility. These protocols are morphological assays, wherein the outcome provided is measured 
by observation of any changes in cell morphology (Jones & Grainger, 2009). 
When performing cytotoxicity assay, each biomarker has its own advantages and disadvantages. As we 
can observe in table 2-5, luminescent formats tend to delivery maximal signal windows in a rapid but 
prolonged way, offering additional utility over fluorescent format method regarding sensitivity detection 
and cost associated, whereas fluorescent format requires short incubation period with the sample (Niles 
et al., 2009) 
Table 2-5 Viability and cytotoxicity Assay Reagents for High Through Screening (HTS). Source: Adapted from (Niles et al., 
2009). 
Assay Type Reagent Name 
Reagent 
Incubation 
Biomaker Detection Method 
Cytotoxicity 
CytoTox-GloTM 15 min Protease(s) Luminescence 
CytoTox-FluorTM 30 min Protease(s) Fluorescence 
CytoTox-ONETM 10 min LDH Luminescence 
Viability 
CellTilter Blue® 2 – 4 hs Reductase(s) Fluorescence 
CellTilter FluorTM 20 min Protease(s) Fluorescence 
CellTilter Glo® 10 min ATP Luminescence 
Cytotoxicity and 
Viability 
MultiTox-Fluor 30 min Protease(s) 
Luminescence/ 
Fluorescence 
MultiTox-Glo 15 – 30 min Protease(s) 
Luminescence/ 
Fluorescence 
 
Development of New Alternative Approach for the Treatment of Melanoma Skin Cancer  
CHAPTER 2: LITERATURE REVIEW AND STATE OF THE ART 
 
 73 
2.4.4 Activity test of cells metabolisms  
The exposure to certain cytotoxic agents can compromise the cell membrane, allowing the cellular 
contents to leak out. Quantitative viability test based on this includes trypan blue and neutral red assay 
(Lee et. al.2006). A weak cationic dye, toluylene red or neutral red, can cross the plasma membrane by 
diffusion, tending to accumulate into the lysosomes within the cell. The discernment between live and 
dead cells is possible if the cell membrane is altered, then the uptake of neutral red is decreased and 
can leak out. The cytotoxicity can be quantified by taking spectrophotometric measurements of neutral 
red uptake at 540nm. The output intensity of the color obtained is inversely proportional to cytotoxicity of 
scaffolds and proportional to the viability of the cell population (Goonoo, Bhaw & Jhurry, 2014).  
Another commonly used colorimetric assay is alamar or resazurin blue, where the non-fluorescent alamar 
blue dye is reduced to a pink fluorescent dye by cell metabolic activity mainly by acting as an electron 
acceptor for enzymes such as NADP7 during oxygen consumption (Goonoo et al., 2014a). 
A different approach is the lactate dehydrogenase release monitoring, known as LDH assay. In this assay 
the LDH is released from damaged cells, then it oxides lactate to pyruvate, promoting conversion of 
tetrazolium salt INT to formazan, which is a water-soluble molecule with the absorbance of 490 nm. The 
LDH released in this assay is directly proportional to the number of lysed or damaged cells (Haslam, 
Wyatt, & Kitos, 2000). 
2.4.5 MTT and MTS Assays  
The most used tests for viability are MTT and MTS: 
• MTS assay (3-(4,5-dimethylthiazol-2-yl)-5-(3- carboxymethoxyphenyl)-2-(4-sulfophenyl)- 2H- 
tetrazolium. “This assay consists of a cell-permeable, soluble tetrazolium salt, and electron 
coupling reagent (phenazine methosulfate, PMS) that is added to the cellular environment after 
the appropriate dosing periods. During incubation with MTS, the dehydrogenase enzymes present 
within the mitochondria of healthy cells reduce the MTS into a dark purple, water- soluble 
formazan compound, which can be quantified with a microplate reader at 490nm. Absorbance 
values measured at zero incubation time are subtracted from the final readings to account for 
                                                        
7 Nicotinamide adenine dinucleotide phosphate, abbreviated NADP. provides the reducing equivalents for biosynthetic reactions 
and the oxidation-reduction involved in protecting against the toxicity of reactive oxygen species (ROS). 
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background absorbance due to the NPs or the solution. The changes are compared to controls 
… and percentages are calculated” (Schrand, Lin, & Hussain, 2012). 
• MTT assay: “The biochemical mechanism behind the MTT assay involves NAD(P)H-dependent 
cellular oxidoreductase enzyme that converts the yellow tetrazolium MTT [3-(4, 5- dimethyl 
thiazolyl-2)-2,5-diphenyltetrazolium bromide] into insoluble (E,Z)-5-(4,5-dimethylthiazol-2-yl)- 1,3-
diphenylformazan (formazan). The formed formazan can be dissolved with dimethyl sulfoxide 
(DMSO) to give a purple color with characteristic absorption at 540 nm. The Intensity of purple 
color is directly proportional to the cell number and thus indicating the cell viability” (Schrand et 
al., 2012). 
2.4.6 Cells studied  
2.4.6.1 Human Dermal Fibroblast Cells 
It is known that human dermal fibroblast (HDF) and extracellular matrix play a pivotal role during wound 
healing process. When the skin is injured, dermal fibroblasts (dFb) and putative precursor cells from 
adjacent intact dermis are attracted to the fibrin-rich wound bed where dFb differentiate and proliferate 
to myofibroblasts (MFb) upon stimulation by local cytokines (Watarai et al., 2015). Transforming growth 
factor beta 1 (TGFβ) and platelet-derived growth factor (PDGF) and macrophages are functional mediators 
supporting differentiation and proliferation (Werner & Grose, 2003). This process is followed by the 
differentiation from dFb to alpha smooth muscle actin (αSMA) expressing MFb in the presence of 
mechanical stress and TGFβ. Finally, the differentiated MFb can synthesize major components of the 
granulation tissue like fibronectin and collagen fibers, contracting the wound (Tomasek et. al., 2002).  
 In case of disturbed wound healing such as chronic venous insufficiency, diabetes or infections, and 
large wounds as burns, engineered biomaterials should provide an effective sterile and fast wound 
closure, at the same time facilitate the initiation of endogenous wound repair. In that context biomaterials 
should be tested in dFb, to assure its effectiveness by forming a beneficial micro-milieu that provides key 
functions of the natural extra-cellular environment, supporting differentiation, adhesion, and proliferation 
of dFb (Watarai et al., 2015).  
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2.4.6.2 Murine Melanoma Cells (B16) 
Malignant melanoma cells have enhanced proliferation and survival abilities, the major reason for this 
behavior is their anti-apoptosis capacity, which is a problem faced by clinical chemotherapy drug tolerance 
(Zhang et al., 2014). In addition to that, chemotherapy treatment is very invasive for patients having a 
low self-immune defense. This is a complex disease that arises through multiple etiologic pathways. A 
limited number of treatments are available for melanoma medical application, most of patients with a 
more aggressive form of the disease with neither long-lasting nor effective treatment presently exists 
decline treatment (Yang et. al., 2013). Although, the major etiologic agent in the development of skin 
cancer is ultraviolet radiation (UVR) exposure, which is responsible for some gene mutation, such as 
MAPK- ERK, which includes the cascade of  BRAF, NRAS, MEK1/2 and ERK 1/2proteins, involved in the 
control of cell proliferation, growth and migration (Colombino et al., 2012). Mutations in this pathway 
may play a major role in the progression and development of melanoma cancer (Casula et al., 2009). 
The National Comprehensive Cancer Network (NCCN) guidelines metastatic melanoma can be treated 
with dacarbazine (DTIC) which is FDA drug approved (Jilaveanu, Aziz, & Kluger, 2009), also with 
paclitaxel, temozolomide; these treatments are not specific MEK and BRAF inhibitors (Anderson et al., 
2013). 
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3 CHAPTER 
 
EXPERIMENTAL DEVELOPMENT 
 
The experimental session of this doctoral thesis was possible, due to the agreement between the Centre 
for Textile Science and Technology, University of Minho- Portugal, the National University of Singapore -
NUS (Center for Nanofibers & Nanotechnology - Department of Mechanical Engineering), Singapore Eye 
Research Institute - SERI (Department of anti- infectiveness research) and Nanyang Technological 
University- NTU – Lee Kong Chian School of Medicine (Department of experimental medicine). 
As a multidisciplinary research, it was necessary to follow the specific and unique guidelines of each 
research group. Different steps of the practical part were made in different institutes, so the protocol used 
to develop each of the following topics are described as used at the department. The protocol may differ 
from one University to the other. We followed all the chemical and biological safety procedures, 
accordingly to in-house training of each department. 
For this study we used Linear (Mn~20,000, catalogue no. 764965, Sigma) and branched (Mn ~10,000, 
catalogue no. 408727, Sigma) polyethyleneimine hydrochloride, Polycaprolactone (Mn~80,000, 
catalogue no.440744, Sigma), Dulbecco’s Modified Eagle’s Medium (DMEM), antibiotics, trypsin-EDTA 
and fetal bovine serum (FBS) were purchased from Gibco (ThermoFisher Scientific, Singapore). CellTiter 
96® AQueous One solution was purchased from Promega (Singapore). Human dermal fibroblast and 
melanoma B16 culture was from American Type Culture Collection (Manassas, VA, USA). 
3.1 Electrospun Mats 
For this study were developed 5 different mats, 10% w/v of polycaprolactone (PCL), 10% w/v of PCL 
blended with 2% and 5% of linear polyethyleneimine (LPEI) and 10% w/v of PCL blended with 2% and 5% 
of branched polyethyleneimine (BPEI), respectively. All the mats were based on 10% w/v of PCL, which 
was prepared from methanol and chloroform (3:7) solution, left overnight steering at 200rpm, room 
temperature. Identical conditions were used for the preparation of mats containing 2% and 5% of LPEI 
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mats and 2% and 5% of BPEI mats.  The solutions left overnight were transferred to a polypropylene 
plastic syringe with 27G stainless steel blunted. The solution of each copolymer was extruded at an 
applied voltage of 15kV from a high voltage power supply (Gamma High Voltage Research, Inc., FL, USA), 
and the distance between the collector and the needle (flattened aluminum foil with cover slips (15mm) 
was set at 13 cm at a feed rate of 1ml/h (KD 100 Scientific Inc., MA, USA). The electrospinning process 
was made for 45 minutes for all mats. For simplicity, the mats were labeled as follows: PCL, PCL_2LPEI, 
PCL_5LPEI, PCL_2BPEI and PCL_5BPEI. The development process of electrospun mats as well the 
labeling and sterilization methods can be observed in Figure 3-1, Figure 3-2 and Figure 3-3, respectively. 
 
 
Figure 3-1 Electrospinning process. (A) coverslips on aluminum foil. (B) Electrospinning apparatus. (C) Nanofibers on 
coverslips. (D) Removing electrospun mats from aluminum foil. (E) Separation of different of electrospun mats for further tests. 
 
 
 
 
Development of New Alternative Approach for the Treatment of Melanoma Skin Cancer  
CHAPTER 3: EXPERIMENTAL DEVELOPMENT 
 
 79 
 
Figure 3-2 Labeling the electrospun mats for biological tests. of PCL, PCL_2LPEI, PCL_5LPEI, PCL_2BPEI, PCL_5BPEI. 
Abbreviations: PCL: -poly-(ε-caprolactone), PCL_2LPEI: poly-(ε-caprolactone) blended with 2% of linear Polyethyleneimine, 
PCL_5LPEI: poly-(ε-caprolactone) blended with 5% of linear polyethyleneimine, PCL_2BPEI: poly- (ε-caprolactone) blended 
with 2% of branched Polyethyleneimine, PCL_5BPEI: poly-(ε-caprolactone) blended with 5% of branched Polyethyleneimine, 
TCP: tissue culture plate. 
 
Figure 3-3 Sterilization of all electrospun mats prior biological test, under UV radiation for 30 min in the fume hood. 
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3.2 Water Contact Angle (WCA) 
The surface wettability of electrospun mats was determined by dynamic water contact angle 
measurements on a VCA Optima Surface Analysis system (AST products, MA, USA). This assay was 
carried by dropping 1µl of distilled water on the surface of the mats. The reported values were determined 
from three independent triplicate experiments, after 8 seconds of plasma radiation for hydrophobicity 
surface modification. This procedure was performed for all mats. Water contact angle experiment can be 
observed in Figure 3-4 and Figure 3-5. 
 
Figure 3-4 Water contact angle apparatus. 
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Figure 3-5 Dynamic water contact angle measurements on a VCA Optima Surface Analysis system. (B) dropping 1µl of distilled 
water on the surface of the mats. (C) Image obtained from VCS system allowing the measurement of water contact angle. 
3.3 Plasma Treatment 
Plasma treatment is typically used to modify the physical and chemical surface properties of polymers 
without affecting their bulk characteristics. It is thus commonly used to tailor surface adhesion and wetting 
properties by changing the surface chemical composition of the polymers. The application of oxygen 
plasma on polymers substrates has generated promising results on promoting cell growth owing to the 
incorporation of hydrophilic and oxygen functional group. The surface treatment for all scaffolds was 
conducted in a plasma chamber (Plasma Electronic PICCOLO) equipped with 13.56 MHz radio frequency 
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plasma generator. Plasma treatments were performed under the same condition with plasma power of 
120 W, the flow rate 100 mL min-1 for 8 seconds under a total pressure of 20 Pa. 
3.4 Morphological characterization by SEM Imaging 
The scanning electron microscopy analysis of all mats was performed on a FE- SEM (FEI-QUANTA 200F, 
The Netherland), accelerating voltage of 15KV after sputter coating the samples with gold. The Images 
Analysis Software was used to estimate the average diameter for various scaffolds. To evaluate the 
diameter of each sample, ~100 nanofibers diameters were randomly selected and used to measure the 
respective diameter. For the scaffolds seeded with cells, the cells were fixed with 300 µl of 3 % of 
glutaraldehyde in cold PBS. Then the scaffolds were washed with distilled water to remove glutaraldehyde. 
Then, each well was washed for 15 min with ethanol of 30%, 50%, 75%, 90%, 100%. The wells were 
treated with 200 µl of hexamethyldisilazane (HMDS), left overnight in the fume hood. Each sample was 
coated with gold and analyzed under SEM.  
3.5 Fourier- transform infrared spectroscopy (FT-IR) 
The infrared spectrum was recorded using Nexus 670 intelligent FTIR spectrometer by compressing all 
mats scaffolds: PCL, PCL_2LPEI, PCL_5LPEI, PCL_2BPEI and PCL_5BPEI.  In this study, FTIR 
spectroscopy was used to detect the functional group´s composition of all electrospun mats. The tested 
wavelength ranged from 4000 to 500 cm-1. 
3.6 Determination of Mechanical Properties 
The determination of mechanical parameters such as Work of Failure, Failure Strain, Young’s Modulus 
and Tensile Strength, was done following the protocol ASTMD882-02, for all the electrospun mats. To 
carry out the experiment was used, at ambient conditions, a tabletop tensile tester (Intron 5345, USA) 
using a capacity of the load cell of 10 N, see Figure 3-6 and Figure 3-7. The mats were cut into rectangular 
strips of 1cm x 3 cm, therefore, the thickness of each sample was measured by micrometer caliper. The 
last step was done by placing each sample on the gripping unit of the tabletop tensile tester at a crosshead 
speed of 5 mm min -1. The results reported are the average of 3 independent measurements. 
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Figure 3-6 Tabletop tensile tester. 
 
Figure 3-7 (A) Test of Mechanical properties using a capacity of the load cell of 10 N. (B) electrospun mats cut into rectangular 
strips of 1cm x 3 cm. (C) Failure point of electrospun mats. 
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3.7 Cell culture 
3.7.1 Human Dermal Fibroblasts (HDF) and Murine Melanoma Cells B16 
HDF and B16 cells were cultured in DMEM supplemented with 10% of FBS and antibiotics. We used 75 
cm2 cell culture flask. Both cells were incubated at 37ºC in humidifier CO2 incubator for 1 week and fed 
with fresh complete DMEM every 3 days.  It was used trypsin- EDTA and the cells were replated after cell 
counting using hemocytometer. For cell seeding into the electrospun mats, all the mats were collected 
on 15 mm coverslips and sterilized for 1 hour under UV radiation, plated in 24 well plates, to prevent 
scaffolds lifting up, the coverslips were plated with a stainless steel ring. The mats were washed with 10 
nM PBS (7pH) three times for 15 min each, to remove any possible residual solvent and left overnight in 
complete DMEM. The HDF and B16 cells were seeded at a density of 2 x104 cells well -1 on PCL, 
PCL_2LPEI, PCL_5LPEI, PCL_2BPEI and PCL_5BPEI scaffolds. Tissue culture plate (TCP) served as 
positive controls. 
3.8 CMFDA- 5-Chloromethylfluorescein Diacetate 
CMFDA is a cell penetrating dye and readily cleaved by the intracellular esterases present in live cells, 
thus producing green- fluorescent calcein. After 3, 6 or 9 days of cell growth, the complete medium was 
removed from the 24-well plates and the cells were fed with DMEM medium. The scaffolds were then 
incubated with 20 ml CMFDA dye (final concentration 25 mM in medium) for 2h at 37ºC. Thereafter, the 
CMFDA-medium was removed, and 1 ml complete medium was added to the cells and incubated 
overnight. Before imaging by confocal microscopy, cells were treated with Cytiva Cell Health Reagents for 
1 h to determine cell count, nuclear morphology and cell viability. Confocal images with z-stacks were 
acquired with 405, 488 and 561 nm lasers excitation using Zeiss LSM800 Airyscan a Plan-Apochromat 
X 40/1.3 oil immersion objective lens. To quantify cell viability, images were acquired by an automated 
microscope INCellAnalyzer 2200 (GEHealthcare Life Sciences), 9 randomly selected fields/samples using 
a X 10 objective. Quantitative live/dead cell analysis of the acquired images was performed with IN Cell 
Investigator software (GE Healthcare Life Sciences). 
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3.9 Sirius Red Collagen 
The fibrous scaffolds were collected on 15mm coverslips and sterilized under UV radiation for 3 hours. 
The scaffolds were placed in 24 well plates with stainless steel rings to avoid lifting up the scaffolds from 
the coverslips. Each scaffold was then washed three times with 10 mM PBS (pH 7), each wash was left 
for 15 minutes, aiming to remove any residual solvent. The scaffolds were finally soaked with completed 
media overnight.  The HDF cells were seeded at the density of 2 x 103 cells well -1. The plates were kept 
in the incubator at 37ºC in humidified CO2 for 10 days and fed with fresh complete medium every 3 days. 
At the days 6 and 10 after the incubation. The plates were stained for Sirius assay. The cells were fixed 
with 500µl of 10% of formaldehyde, then was added 200 µl of hematoxylin for one hour. Then the wells 
were washed 3 times of 15 minutes each with DI water, added 250µl of 0.1% Sirius red solution, which 
was left in the incubator for one hour. The wells were finally washed with 100% ethanol and observed 
under the Leica microscope for collagen release profile. 
3.10 MTS Assay 
Cell viability was measured using the 3-(4,5-di- methylthiazol-2-yl)-5-(3-carboxymethyl-oxyphenyl)-2-(4- 
sulfophenyl)-2H-tetrazolium (MTS) colorimetric assay. The kit (CellTiter 96s Aqueous One Solution Cell 
Proliferation Assay) was purchased from Promega and the µmeasurement was conducted according to 
the manufacturer’s directions. Before the MTS testing, the culture medium was pipetted out from the 24-
well tissue culture plate and 500 ml new fresh culture medium was added to every well. A hundred 
microliters of CellTiter 96s Aqueous One Solution Reagent was added into every well. After culturing for 
4 h, the deep colored culture medium was pipetted out and added into a 96- well plate (100µl/well) and 
the absorbance at 490nm was recorded using an ELISA plate reader, see Figure 3-8. Samples with culture 
medium but without cells were set as a control to get background absorbance to be subtracted from the 
absorbance of the cell-containing wells. The overall summary of the practical work can be seen in Figure 
3-9. 
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Figure 3-8 MTS Assay. A-) 24 well culture plate seeded with b16 Melanoma cells. B-) After culturing for 4 hours the colored 
culture with CellTiter96 was plated into 96 well plate (100µl/well). C-) Elisa plate reader at 490nm absorbance.  
 
Figure 3-9 Overall summary of the present work. Electrospinning of PCL, PCL_2LPEI, PCL_5LPEI, PCL_2BPEI, 
PCL_5BPEI.The electrospun mats displayed excellent mechanical properties show good cells adhesion and proliferation for 
HDFs, and great collagen release profile, for Melanoma cells the results indicate good adhesion on the mats surface, high 
cytotoxicity for composites scaffolds, specially PCL_2BPEI, compared to TCP. 
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4 CHAPTER 
 
RESULTS AND DISCUSSION 
 
4.1 Morphological Analysis of Electrospun Nanofibrous Scaffolds 
The SEM micrographs of the nanofibers obtained at a different concentration of LPEI and BPEI are shown 
in Figure 4-1. The images reveal that all of the fibers are continuous and random with few beads. At 1µm 
scale bar, it can be seen that the overall parts of the obtained fibers all have good fibrous morphology, 
suggesting that blending of PCL_2LPEI, PCL_5LPEI, PCL_2BPEI and PCL_5BPEI does not destroy the 
fibrous structure, it is not presented any collapse nor breakage. The diameters and morphologies of 
electrospun nanofibers were strongly affected by LPEI and BPEI concentration and type of polymer used 
to blend with PCL. For LPEI mats, it can be seen that the average of electrospun nanofiber decreases 
with an increase of LPEI in the solution. The standard deviation of all diameters found in each electrospun 
mats was calculated. Accordingly, the fiber diameter decreased from 331±74 nm for neat PCL fibers 
(which were named as PCL in the experiment) to 258 ±109 nm for PCL_5LPEI. This is because of the 
cationic characteristics of LPEI enhanced the conductivity solution. When analyzing PCL blended with 
BPEI, the fiber diameter distributions demonstrate that the diameter of the average fibers diameter 
increases with increased concentration of BPEI. The diameter was increased from 331±74 for neat PCL 
to 419 ± 233 nm for PCL_5BPEI. From SEM observations, the electrospun fibers showed numerous 
porous structures among the fibers, which could improve the contact cell to scaffold mats, helping the 
adhesion process.   
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Figure 4-1 Scanning electron microspe ( SEM) images of all nanofibers. Scale bar = 1µm 
4.1.1 Wettability 
The surface properties of polymer scaffolds play a major role in the interaction between cells and the 
matrix. Among many factors influencing the surface chemistry of scaffolds, the balance of hydrophilicity 
and hydrophobicity is very important for cell adhesion. Water contact angle assay can be used to reflect 
the hydrophilicity of the scaffolds, since cells may attach and proliferate less well on scaffolds having a 
wettability that is higher than 90º. All the scaffolds prepared in this study showed hydrophobic behavior 
with a contact angle higher than 87°, as we can observe in Figure 4-2 for non-treated mats. To ameliorate 
the hydrophilic properties, the scaffolds undergone a plasma treatment for 8s. The observed results after 
plasma treatment are shown in Figure 4-2. After plasma treatment, we could observe the improvement 
of hydrophilic properties. The contact angles were decreased from 130º to 32º, 136º to 31º, 135º to 36, 
136º to 31º, 87º to 31, for neat PCL, PCL_2LPEI, PCL_5LPEI, PCL_2BPEI PCL_5BPEI, respectively. 
The hydrophilic properties of the nanofibrous scaffolds are directly proportional to the rate of water 
absorbance. The improved wettability is expected to be beneficial for cell attachment.  
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Figure 4-2 Water contact angle assay of all mats, namely PCL, PCL_2LPEI, PCL_5LPEI, PCL_2BPEI, PCL_5BPEI. 
4.1.2 Characterization by FT-IR 
FTIR analysis was used to detect the possible changes in the chemical structure of the electrospun 
materials, Figure 4-3. Regarding PCL, spectra showed that the main absorption of the PCL such as 
asymmetric and symmetric stretching of the methylene groups (2944 and 2865 cm_1), banding at 1294 
cm-1, corresponding to C-O stretching of the crystalline phase of the PCL and 1242 and 1189 cm-1 
associated with asymmetric (C-O-C) and symmetric (OC-O) stretching, respectively, and stretching of the 
ester carbonyl (O-C=O) at 1726 cm-1. A close inspection of PCL mats spectra showed that the presence 
of a small band close to 3439 cm-1, attributed to O-H stretching vibration and the 1726 cm-1 peak exhibits 
a small shoulder located at 1708 cm-1, which can be associated with COOH groups. The spectra show 
characteristic absorption peaks of PEI at 1580 and 1460 cm -1, in the linear PEI, the amide group I peak 
is at 1648 cm-1, and 1552 cm-1 corresponds with the amide II peaks. The branched PEI shows it 
characteristic absorption bands at about 3440 and 1654 cm-1 assigned to the stretching vibration of the 
group -NH2. 
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Figure 4-3 FT-IR characterization of electrospun mats prepared under various condition. 
4.1.3 Mechanical Properties 
The mechanical properties of PCL, PCL_2LPEI, PCL_5LPEI, PCL_2BPEI and PCL_5BPEI nanofibrous 
scaffolds are shown in Table 4-1, and the scaffolds revealed a characteristic semilinear stress-strain curve 
as shown in Figure 4-4. The Young’s modulus obtained for PCL, PCL_2LPEI, PCL_5LPEI, PCL_2BPEI, 
and PCL_5BPEI were 7.2±2.0 MPa, 15.57±6.8 MPa, 15.18±3.97 MPa, 5.97±3.27 MPa, 7.53±3.96 
MPa, respectively. The tensile properties of PCL_5LPEI and PCL_2LPEI, were higher when compared to 
the PCL, and lower for PCL_5BPEI and PCL_2BPEI. The observed results proved that the increase of 
concentration of PEI polymer from 2 to 5% results increased tensile stress. The results show that PCL 
blended with LPEIs have better mechanical properties to the scaffolds than BPEIs scaffolds, which have 
almost the same mechanical properties as PCL. The blend of PEIs may reduce the tensile break of 
nanofibrous scaffolds observed in Figure 4-4. Mechanical stability of the scaffolds is desirable to provide 
cell growth and proliferation and degrade itself while the patient natural ECM starts regenerating the 
injured body sites. 
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Figure 4-4 Tensile stress-strain curves of PCL, PCL_2LPEI, PCL_5LPEI, PCL_2BPEI, and PCL_5BPEI. Abbreviations: PCL: -
poly-(ε-caprolactone), PCL_2LPEI: poly-(ε-caprolactone) blended with 2% of linear polyethyleneimine, PCL_5LPEI: poly-(ε-
caprolactone) blended with 5% of linear polyethyleneimine, PCL_2BPEI: poly- (ε-caprolactone) blended with 2% of branched 
polyethyleneimine, PCL_5BPEI: poly-(ε-caprolactone) blended with 5% of branched polyethyleneimine. 
Table 4-1 Mechanical Properties of mats prepared under various conditions. The table shows Tensile strength (MPa), Failure 
Strain (%), Young´s Modulus (MPa) and Work of Failure (MJm-3). 
Sample Tensile Strength 
(MPa) 
Failure Strain (%) Young´s Modulus 
(MPa) 
Work of Failure 
(MJm-3) 
PCL 7.8 ± 1.5 135.8 ± 8.2 7.2 ± 2.0 6.4 ± 1.0 
PCL_2LPEI 11.1 ± 4.5 78.2 ± 12.4 15.6 ± 6.8 5.1 ± 2.0 
PCL_5LPEI 12.5 ± 3.0 82.4 ± 4.5 15.2 ± 4.0 2.4 ± 0.6 
PCL_2BPEI 4.0 ± 1.0 98.3 ± 3.8 5.9 ± 3.3 2.4 ± 0.6 
PCL_5BPEI 4.2 ± 2.1 87.3 ± 33.2 7.5 ± 4.0          2.6 ± 2.1 
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4.2 Evaluation of Biocompatibility of the Scaffolds for Human Dermal 
Fibroblast 
4.2.1 Scanning Electron Microscopy – SEM 
The design of scaffolds involves certain specific requirements of the scaffolds for tissue/ skin 
reconstruction, it should have adequate pore size for seeding the cells, biodegradability, and diffusability 
through the matrix. We proposed PCL, -poly-(ε-caprolactone); PCL_2LPEI, poly-(ε-caprolactone) blended 
with 2% of linear Polyethyleneimine; PCL_5LPEI, poly-(ε-caprolactone) blended with 5% of linear 
Polyethyleneimine; PCL_2BPEI, poly- (ε-caprolactone) blended with 2% of branched Polyethyleneimine; 
PCL_5BPEI, poly-(ε-caprolactone) blended with 5% of branched Polyethyleneimine fibrous mats for skin 
tissue engineering applications and hence fibrous mats were evaluated for its suitability with human 
dermal fibroblasts. Cell attachment study was carried using human dermal fibroblast. HDFs cells show 
good attachment, spreading and proliferation. We used tissue culture plate as control, followed by PCL, 
PCL_2LPEI, PCL_5LPEI, PCL_2BPEI, PCL_5BPEI. In all mats is possible to observe the attachment of 
cells. It is important to note that we conducted the study for one week, changing medium every three 
days. In Figure 4-5 and Figure 4-6, we can observe the cell proliferation for day 4 and day 7, respectively. 
The images show the HDFs dispersion and morphology within the fibrous mats observed by SEM. By day 
7, cells covered the surface of the 3D porous structure, and closure to the interconnected pores. The 
HDFs on PCL_2LPEI, PCL_5LPEI, PCL_2BPEI, PCL_5BPEI expressed good cell-cell contact with almost 
no exposed fibers, the improved biocompatibility and hydrophilicity of the electrospun mats after plasma 
treatment, as previously mentioned, act to promote proliferation and migration of the cells. The cell 
adhesion on a surface is strongly influenced by the balance of hydrophobicity and hydrophilicity. The cells 
can adhere, grow and spread more easily on the moderate hydrophilic substrate than on very hydrophilic 
or hydrophobic ones. This is required for skin tissue engineering and wound healing as HDFs need good 
cell-cell contact and strong cell ECM interaction.  
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Figure 4-5 Scanning electron microscope ( SEM) images show the biomaterial-cell interaction on the day 1. PCL, PCL_2LPEI, 
PCL_5LPEI, PCL_2BPEI, PCL_5BPEI and TCP on day 4. Scale bar = 1µm.  Abbreviations: PCL: -poly-(ε-caprolactone), 
PCL_2LPEI: poly-(ε-caprolactone) blended with 2% of linear Polyethyleneimine, PCL_5LPEI: poly-(ε-caprolactone) blended with 
5% of linear Polyethyleneimine, PCL_2BPEI: poly- (ε-caprolactone) blended with 2% of branched Polyethyleneimine, 
PCL_5BPEI: poly-(ε-caprolactone) blended with 5% of branched Polyethyleneimine. 
 
Figure 4-6 Scanning electron microscope ( SEM) images show the biomaterial-cell interaction on the day 6. PCL, PCL_2LPEI, 
PCL_5LPEI, PCL_2BPEI, PCL_5BPEI and TCP on day 7. Scale bar = 1µm.   Abbreviations: PCL: -poly-(ε-caprolactone), 
PCL_2LPEI: poly-(ε-caprolactone) blended with 2% of linear Polyethyleneimine, PCL_5LPEI: poly-(ε-caprolactone) blended with 
5% of linear Polyethyleneimine, PCL_2BPEI: poly- (ε-caprolactone) blended with 2% of branched Polyethyleneimine, 
PCL_5BPEI: poly-(ε-caprolactone) blended with 5% of branched Polyethyleneimine. 
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4.2.2 HDFs Cell Viability- MTS Assay 
Cell viability was monitored after 1,4, 7 and 10 days of incubation time by the colorimetric MTS assay 3-
(4,5- dimethylthizol-2-yl)-5-(3-carboxymethoxyphenyl)-2(4- sulfophenyl)-2H-tetrazolium, inner salt (CellTitel 
96 Aqueous one solution cell proliferation assay). The HDFs viability was first revealed on day 1, after 24 
hours of incubation time. In this experiment, we used tissue culture plate (TCP), as the negative control 
and cells treated with Nocodazole as the positive control. All mats PCL, PCL_2LPEI, PCL_5LPEI, 
PCL_2BPEI, PCL_5BPEI, when compared to TCP show no cytotoxicity after 24 hours, the well treated 
with Nocodazole presents high toxicity, this was thought to serve as a comparison for this viability assay. 
Moreover, their viability on PCL, PCL_2LPEI, PCL_5LPEI, PCL_2BPEI, PCL_5BPEI did not vary during 
the observation, the same behavior has been observed for HDFs seeded on TCP, see Figure 4-7. 
After we observed no cytotoxic for the mats, we follow-up the HDFs cells during 10 days after seeding. 
The follow up viability is presented in Figure 4-8. 
 
Figure 4-7 MTS assay reading of electrospun mats after 24 hours of incubation time of human dermal fibroblast (HDF) cells. 
(****, represents high cytotoxicity). Absorbance Index 490 nm. 
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On day 4 it is possible to observe higher cell viability on TCP, followed by PCL, PCL_2LPEI, PCL_2BPEI, 
the cell viability for PCL_5LPEI and PCL_5BPEI were almost the same value. On day 7, although we 
variation of cell growth on all seeded mats, none of them are toxic because cell viability is still present. It 
is possible to observe, better cell viability on PCL, followed by TCP and PCL_2LPEI, PCL_5LPEI, 
PCL_2BPEI, and PCL_5BPEI. Surprisingly on day 10, the viability on PCL mat decreased compared to 
day 7, the PCL_2LPEI reaches almost the same cell viability as TCP, followed by PCL_2BPEI and 
PCL5LPEI this might be too high cell proliferation and attachment to the surface. In the same graphic, 
we can observe that PCL _5BPEI had lower viability rate compared to the others mats, we cannot assure 
that this lower proliferate indicates cytotoxicity, on the contrary, toxic biomaterial do not present cell 
growth viability as PCL_5BPEI presented. From this data, we can state that none of the mats are toxic 
for HDFs cells. 
 
Figure 4-8 MTS assay reading of electrospun mats after 1, 4, 7 and 4 days of incubation time of human dermal fibroblast 
(HDF) cells. Absorbance Index 490 nm. 
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4.2.3 CFMDA 
We examined biological properties of Human Dermal Fibroblast, seeded into PCL, PCL_2LPEI, 
PCL_5LPEI, PCL_2BPEI, PCL_5BPEI and TCP scaffolds, in terms of assessing their cytocompatibility to 
enhance proliferation and cell adhesion. The cells were seeded on PCL, PCL_2LPEI, PCL_5LPEI, 
PCL_2BPEI, PCL_5BPEI mats. Cells seeded on the tissue culture plate (TCP) served as control. After 
four days post seeding (p.s.) of HDF on various scaffolds, the cells were stained with green CMFDA (5-
Chloromethylfluorescein diacetate) to obtain semiquantitative information about living and dead cells. All 
the scaffolds studied displayed no discernible cytotoxicity to HDF cells, therefore, confirming the 
biocompatibility of all scaffolds for HDF. The confocal images are shown in Figure 4-9. Interestingly, the 
scaffold 5_LPEI has shown a decreased HDF proliferation, although, no cytotoxicity is presented.  
 
Figure 4-9 CMFDA confocal imagens on TCP, PCL 10%, PCL 10%_LPEI2%, PCL 10%_LPEI 5%, PCL 10%_ BPEI 2%, PCL 10%- 
BPEI 5%. Scale bar = 20µm. Abbreviations: PCL: -poly-(ε-caprolactone), PCL_2LPEI: poly-(ε-caprolactone) blended with 2% of 
linear Polyethylenimine, PCL_5LPEI: poly-(ε-caprolactone) blended with 5% of linear polyethylenimine, PCL_2BPEI: poly- (ε-
caprolactone) blended with 2% of branched Polyethylenimine, PCL_5BPEI: poly-(ε-caprolactone) blended with 5% of branched 
Polyethylenimine, TCP: tissue culture plate. 
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4.2.4 Sirius Red Collagen Assay 
In the ECM formation, fibroblasts are essential in their tissue of residence. In the dermis, they can release 
collagen and other important components of the ECM. During the wound healing process, the fibroblasts 
are essential for wound closure synthesis of the provisional as well as remodeled scar matrix. Here, we 
tested whether human dermal fibroblast cultured in PCL, PCL_2LPEI, PCL_5LPEI, PCL_2BPEI, 
PCL_5BPEI electrospun scaffolds could release collagen on these subtracts. In Figure 4-10, is possible 
to observe the collagen expressed in human dermal fibroblast cells, after 6 days of incubation time. It 
results in a layer of decellularized extracellular matrix produced by the cells. This extracellular matrix was 
stained for collagen with Sirius red. As we can observe, the reddish color in the followed figure represents 
the collagen expression in HDFs. Collagen deposition was higher into PCL_2LPEI, PCL_5LPEI, 
PCL_2BPEI subtracts than TCP, PCL, and PCL_5BPEI. The optical microscopy images of scaffolds 
stained with Sirius Red Collagen for 6 days support the above data, where high intensity of staining 
materials was observed on PCL_2LPEI, PCL_5LPEI, PCL_2BPEI electrospun scaffolds displaying an 
overall enhancing effect in collagen expression in HDFS cells and proving these scaffolds as an 
indispensable method for the fabrication of superior nanofibrous scaffolds for skin tissue engineering. 
 
Figure 4-10 Sirius red collagen assay, observation of collagen release on the day 6. Scale bar = 50µm. 
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4.3 Evaluation of Cytotoxicity for Melanoma Cells 
4.3.1 Scanning electron microscopy – SEM 
The design of scaffolds involves certain specific requirements of the scaffolds for melanoma (B16) 
cytotoxic effect, it should have adequate pore size for seeding the cells, biodegradability, and diffusability 
through the matrix. We proposed PCL, PCL_2LPEI, PCL_5LPEI, PCL_2BPEI, PCL_5BPEI fibrous mats 
as cytotoxic functional biomaterials for melanoma as an alternative approach for melanoma treatment, 
hence fibrous mats were evaluated for its cytotoxicity activity with B16 melanoma cells. Cell attachment 
study was carried using B16 cells, the SEM micrographics are presented in Figure 4-10. B16 cells show 
good attachment, spreading and proliferation. We used tissue culture plate as control, followed by PCL, 
PCL_2LPEI, PCL_5LPEI, PCL_2BPEI, PCL_5BPEI. In all mats is possible to observe the attachment of 
the cells. The images presented in Figure 4-10, were taken 24 hours after seeding. The images show 
B16 cells dispersion and morphology within the fibrous mats observed by SEM. TCP presents the cell 
morphology without any treatment, only medium. Differently than the image from TCP, in all mats the 
B16 cells grow in a different manner. The morphological image of B16 on PCL_5LPEI have the same 
morphology that TCP. On the mats PCL, PCL_2LPEI and PCL_2BPEI the B16 cells do not present the 
wounded morphology of health B16 melanoma cells, it is possible to observe that the cells are flatted 
and spread out along the fibers. In PCL_5BPEI SEM image, is clearly noted the degradation of cell the 
membrane, although still attached to the surface of the mats. As mentioned previously the cell adhesion 
on a surface is strongly influenced by the balance of hydrophobicity and hydrophilicity. The cells can 
adhere, grow and spread more easily on the moderate hydrophilic substrate than on very hydrophilic or 
hydrophobic ones. Cell attachment is required for drugs delivery system. 
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Figure 4-11 Morphology of B16 melanoma cells seeded on various mats. Representative SEM image showing features of B16 
after 24 hours p.s. onto PCL, PCL_2LPEI, PCL_5LPEI, PCL_2BPEI and PCL_5BPEI. Scale bar = 10 µm. 
4.3.2 Melanoma Cell Viability- MTS Assay 
Cell viability was monitored for 24 hours of incubation time by the colorimetric MTS assay 3-(4,5- 
dimethylthizol-2-yl)-5-(3-carboxymethoxyphenyl)-2(4- sulfophenyl)-2H-tetrazolium, inner salt (CellTitel 96 
Aqueous one solution cell proliferation assay). In this experiment we used tissue culture plate (TCP), as 
the negative control and cells treated with Doxorubicin, which is a potent anticancer drug, serving as 
positive control. When compared to TCP, the mats PCL, PCL_2LPEI, PCL_5LPEI, presented good cell 
viability, which is the contrary of what we proposed to do as an alternative for anticancer melanoma 
approach. On the other hand, the mats PCL_2BPEI and PCL_5BPEI had the higher anticancer activity 
when compared to our positive control Doxorubicin. This is an indication that from all mats developed, 
the ones that have better cytotoxic effect for the B16 cells, are the PCL loaded with 2 and 5% of BPEI, it 
can be observed in Figure 4-12. 
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Figure 4-12 MTS assay reading of electrospun mats after 24 hours of incubation time of murine melanoma cells B16. (****, 
and *** represents high cytotoxicity). Absorbance Index 490 nm. 
4.4 Confocal microscopy 
To gain insights of cell morphology, confocal images of the melanoma cells cultured on various scaffolds 
are shown Figure 4-13, 24 hours after seeding the cells. The cells were labeled with Hoechst and 
Phalloidin Rhodamine Actin, for better visualization of the nucleus and membrane of the cells respectively. 
By taking advantage of the photoluminescent properties of the scaffolds, we used confocal microscopy to 
confirm the integrity of the fiber mats after 24 hours in the cell culture.  It is possible to observe that the 
multiple layers for TCP, the cells had a normal proliferation and growth, however, we had a different 
outcome for PCL_2LPEI, PCL_5LPEI, PCL_2BPEI, and PCL_5BPEI, the images suggest cytotoxicity for 
the cells, the membrane becomes rounded, which indicates cell death. Interesting, in our study, we did 
not use any green stain, which was observed on the layer of the scaffolds for PCL, PCL_2LPEI, 
PCL_5LPEI, PCL_2BPEI, and PCL_5BPEI, this suggests that the melanin produced by melanoma cells 
give green fluorescent color, this is not observed in TCP, which served as control. In addition to that, the 
fluorescent signals from the cells confirmed the stability of the mats in the culture media. 
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Figure 4-13 Confocal images of electrospun mats seeded with murine melanoma cells B16 after 24 hours of incubation time. 
Mats were stained with Hoechst, Phalloidin Rhodamine Actine, then overlayered. 
Next, we performed the same study for HDFs 24 hours after seeding the cells. The cells were analyzed 
with Hoechst and Phalloidin Rhodamine Actin, to have a better insight of the nucleus and membrane of 
the cells respectively. It is possible to observe that nontoxicity is presented in the mats, due to the normal 
proliferation rate and morphology of cells membrane and nucleus of HDFs seeded in PCL_2LPEI, 
PCL_5LPEI, PCL_2BPEI and PCL_5BPEI Figure 4-14. As a comparison on the lower side, we have the 
melanoma confocal images, giving us a clear picture of the toxicity presented in the scaffolds as 
mentioned above for the control the proliferation of melanoma cells. 
 
Figure 4-14 Confocal images of electrospun mats seeded with human dermal fibroblasts (hDFs) and murine melanoma cells 
B16 (Mnoma) after 24 hours of incubation time. Abbreviations: PCL: -poly-(ε-caprolactone), PCL_2LPEI: poly-(ε-caprolactone) 
blended with 2% of linear Polyethyleneimine, PCL_5LPEI: poly-(ε-caprolactone) blended with 5% of linear polyethyleneimine, 
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PCL_2BPEI: poly- (ε-caprolactone) blended with 2% of branched Polyethyleneimine, PCL_5BPEI: poly-(ε-caprolactone) blended 
with 5% of branched Polyethyleneimine, TCP: tissue culture plate. 
Protein kinase C (PKC) family of serine/threonine was one of the first protein kinases to be identified. It 
is a heterogeneous group of enzymes integrating and receiving signals in both normal melanocytes and 
melanoma pathology. The chromatographic purification of PKC shows that this activity was composed of 
at least three distinct species, designated as a, b and g isotypes. Nowadays, it is known that PKC isotypes 
of mammalians are superfamily comprising twelve distinct genes. The members of mammalian, PKC, 
superfamily play an important key on regulatory roles in cellular processes, it has a wide range, from 
fundamentals autonomous activities such proliferation to cellular memory. Comparative analysis over the 
last few years have provided insights and defining a number of regulatory elements in PKC which confer 
to each isotype specific activation signals and location. 
The alteration of PKC enzyme activation and expression contribute directly to the malignant phenotype of 
melanoma in both the tumour suppressive and oncogenic roles. These enzymes are involved in a varied 
array of the biological process including, migration, cell polarity, proliferation, differentiation, and 
apoptosis. PKC enzymes have profound influences on actin cytoskeleton organization and PKCa, which 
have been linked to melanoma invasion, see Figure 4-15. Thus, activation and/or alteration in the 
expression of PKCa cooperate with b3 subunit signalling, this can disrupt stable cell-matrix adhesion and 
facilitate melanoma invasion. The changes in integrin expression and signalling are important to 
melanoma invasion and metastasis. The high expression of the subunit b3 is associated with melanoma 
invasion and progression. 
PKC activation inhibits the growth of melanoma cells while stimulating proliferation of normal melanocytes 
cells. The inhibitory growth effect of PKC activation is due to some PKC enzymes possess tumour 
suppressive functions in melanoma cells (Mason et al., 2010).  
An agonist is a chemical that binds to a receptor and activates the receptor to produce a biological 
response. PKC agonist with differential desensitization/activation specificities holds a promise to the 
development of PKC based therapeutics for melanoma, by having multiple mechanisms of actions, such 
as inducing expression of their target PKC enzyme or disrupting tumour vasculature. 
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Multidrug resistance (MDR) is an important hindrance for cancer therapy. Polymeric gene carriers have 
attracted attention for potential application in the fled of gene therapy, especially for cancer therapy. One 
of the most important approach to avoid side effects is cancer-specific gene delivery. As we know, protein 
kinase (PKs) plays an important role in regulating various cellular functions, so, dysregulation of specific 
PKs activity is closely associated with many diseases, including cancer. As mentioned previously, there 
are various PKs, among them, the PKCa is reported as a suitable marker to distinguish carcinogenic cell 
from healthy cells, once that in tumour cells the PKCa activity is much higher than in healthy cells. The 
buffering capacity of the polyethyleneimine main chain results in polyplexes efficient escape from the 
endosome, showing a clear-cut response towards PKs activity. LPEI and BPEI based carries can be 
generally applicable to any kind of protein kinase, which is specifically activated in disease cells. 
As LPEI and BPEI can target PKCa which has more intense activity in malignance cells and less activity 
in healthy cells, we can observe high cytotoxicity for B16 melanoma cells, and non-cytotoxicity to human 
dermal fibroblast cells, as shown in confocal Figure 4-14.  
 
Figure 4-15 Graphical representation of Protein kinase C, a subunit. 
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5 CHAPTER 
 
FINAL CONSIDERATIONS 
 
5.1 Conclusions 
In this doctoral thesis, we proposed the conception and the development of new electrospun mats, aiming 
high cytotoxicity to melanoma carcinogenic cells B16, with regenerative properties for ECM, achieving 
wound healing and skin regeneration by collagen release. 
The scaffolds developed were produced by biodegradable polymers, approved by the Food and Drug 
Administration (FDA- U.S.). After working in this process, we come to the conclusion that: 
The SEM of electrospun mats obtained from neat PCL and PCL blended with different concentration of 
LPEI and BPEI, both blended at concentrations of 2 and 5%, reveal that all fibers are continuous and 
random with few beads, having good fibrous morphology, suggesting that blending PCL_2LPEI, 
PCL_5LPEI, PCL_2BPEI, PCL_5BPEI does not destroy the fibrous structure, not presenting any breakage 
nor collapse. The diameters and morphologies of all electrospun mats were strongly affected by the 
concentration of LPEI and BPEI used to blend into PCL solution. The diameter was increased from 
331±74 for neat PCL to 419 ± 233 nm for PCL_5BPEI. Also, the SEM observations, lead us to conclude 
that all electrospun mats developed showed innumerous porous structure among the fibers, this 
characteristic could enhance the surface mats to cell interaction, helping cellular adhesion. 
The wettability property of electrospun mats is a crucial characteristic for the surface to cell interaction, 
once that cells may attach and proliferate better on hydrophilic mats surface. It is important to mention 
that a balance between hydrophobic and hydrophilic behavior is necessary. The first mats developed had 
hydrophobic behavior, showing WCA higher than 90º. In order to ameliorate the hydrophobicity of the 
mats, all scaffolds underwent eight seconds of plasma treatment. Then the contact angle was decreased 
from 130º to 32º, 136º to 31º, 135º to 36, 136º to 31º, 87º to 31, for neat PCL, PCL_2LPEI, PCL_5LPEI, 
PCL_2BPEI and PCL_5BPEI, respectively. This improved hydrophilic characteristic on the mats is 
beneficial for cell attachment. 
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Regarding the mechanical properties, the results show that PCL blended with LPEIs have better 
mechanical properties to the scaffolds than BPEIs scaffolds, which have almost the same mechanical 
properties as PCL. The blend of PEIs may reduce the tensile break of nanofibrous scaffolds. Mechanical 
stability of the scaffolds is desirable to provide cell growth and proliferation and degrade itself while the 
patient natural ECM starts regenerating the injured body sites.  
The biocompatibility of the scaffolds was crucial for this study. First, we conduct cell-to-surface interaction 
study, which was made by SEM. The SEM images show the HDFs dispersion and morphology within the 
fibrous mats observed by SEM, by day 7, cells covered the 3D porous structure surface. HDFs on 
PCL_2LPEI, PCL_5LPEI, PCL_2BPEI, PCL_5BPEI expressed good cell-cell contact with almost no 
exposed fibers, the improved biocompatibility and hydrophilicity of the electrospun mats after plasma 
treatment, as previously mentioned, act to promote proliferation and migration of the cells. This 
attachment behavior plays a major role in skin tissue engineering and wound healing process as HDFs 
need strong cell ECM interaction and good cell-cell contact. This was followed by HDFs cell viability 
performed by MTS assay. We followed up the HDFs viability for ten days, from the data obtained we could 
conclude that none of the mats developed had toxicity effect to HDFs cells. The CMFDA assay, helped us 
to obtain semiquantitative information about living and dead cells. All the electrospun mats displayed no 
discernible cytotoxicity to HDF cells, therefore, confirming the biocompatibility of all scaffolds for HDF. 
Interestingly, the scaffold PCL_5LPEI has shown a decreased HDF proliferation, although, no cytotoxicity 
is presented. Last but not least assay to assure collagen expression for the mats developed was the Sirius 
Red collagen. Data showed high intensity of staining materials was observed on PCL_2LPEI, PCL_5LPEI, 
PCL_2BPEI electrospun scaffolds displaying an overall enhancing effect in collagen expression in HDFs 
cells and proving these scaffolds as an indispensable method for the fabrication of superior nanofibrous 
scaffolds for skin tissue engineering. 
The evaluation of cytotoxicity for B16 murine melanoma cells was performed by SEM and MTS assay. 
The SEM images show B16 cells dispersion and morphology after 24 hours of incubation time. The cells 
had good adhesion behavior, this is an important characteristic since that cell attachment is required for 
drug delivery system.  On the mats PCL, PCL_2LPEI and PCL_2BPEI the B16 cells do not present the 
wounded morphology of health B16 melanoma cells, it is possible to observe that the cells are flatted 
and spread out along the fibers. In PCL_5BPEI SEM image, is clearly noted the degradation of the cell 
membrane, although still attached to the surface of the electrospun mats. The Melanoma cell viability 
was monitored after 24 hours of incubation time. When compared to TCP, the mats PCL, PCL_2LPEI, 
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PCL_5LPEI, presented good cell viability, which is the contrary of what we proposed to do as an alternative 
for anticancer melanoma approach. On the other hand, the mats PCL_2BPEI and PCL_5BPEI had the 
higher anticancer activity when compared to our positive control Doxorubicin. 
Another conducted study to gain insights of cell morphology was the confocal image. The first study 
conducted was for the melanoma cells, 24 hours after seeding the cells. The data showed multiple layers 
for TCP, the cells had a normal proliferation and growth, however, we had a different outcome for 
PCL_2LPEI, PCL_5LPEI, PCL_2BPEI and PCL_5BPEI, the images suggest cytotoxicity for the cells, the 
membrane becomes rounded, which indicates cell death. The major morphological differentiation was 
observed in PCL_5LPEI, PCL_2BPEI, PCL_5BPEI. Interesting, in our study, we did not use any green 
stain, which was observed on the layer of the scaffolds for PCL, PCL_2LPEI, PCL_5LPEI, PCL_2BPEI, 
and PCL_5BPEI, this suggests that the melanin produced by melanoma cells give green fluorescent color, 
this is not observed in TCP, which served as control. Next, we conducted the same study for HDFs, we 
gained insights of the nucleus and cells membrane. The data suggest nontoxicity presented in the mats, 
due to the normal proliferation rate and healthy morphological shape of cells membrane and nucleus of 
HDFs seeded in PCL_2LPEI, PCL_5LPEI, PCL_2BPEI, and PCL_5BPEI. 
In conclusion, to mimicking the formation of ECM, which regulates and supports cell activities, we 
developed nanofibrous scaffolds based on PCL, PCL_2LPEI, PCL_5LPEI, PCL_2BPEI, and PCL_5BPEI 
for the use of human dermal fibroblast during the early stage for skin tissue regeneration; this approach 
may be useful for injured skin as burns, diabetic foot ulcers, chronic wounds and to accelerate the wound 
healing process. Surface chemical characterization and morphological analysis confirmed the successful 
formation of PCL and PCL blended with PEIs composite structures. The surface wettability issue was 
overcome by plasma treatment. Biological studies with HDFs shown no toxicity for all mats, do not affect 
the surrounding tissue, it possesses good cell adhesion, cell proliferation and collagen release properties. 
The porous nanofibrous scaffolds interconnection may provide more structural space for HDFs adhesion 
and proliferation, permitting efficient metabolic wastes and nutrients exchanges. Together these data 
demonstrate that PCL blended with PEIs nanofibrous mats can provide multifunctional scaffolds 
properties, ranging from collagen secretion, cell adhesion and proliferation, acting as localized delivery of 
biomolecules to the injured skin, possessing the possibility to accelerate wound healing, useful for skin 
tissue engineering applications. Regarding the B16 murine melanoma cells, we could conclude that 
PCL_2BPEI and PCL_5BPEI had the higher anticancer effect, it is important to note that PCL_2BPEI had 
better cell viability for HDFs, compared to PCL_5BPEI. Protein kinase (PKs) plays an important role in 
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regulating various cellular functions, so, dysregulation of specific PKs activity is closely associated with 
many diseases, including cancer. As mentioned previously, there are various PKs, among them, the 
PKCa is reported as a suitable marker to distinguish carcinogenic cell from healthy cells, once that in 
tumour cells the PKCa activity is much higher than in healthy cells. The buffering capacity of the 
polyethyleneimine main chain results in polyplexes efficient escape from the endosome, showing a clear-
cut response towards PKs activity. Together, all these data suggested that PCL_2BPEI composite 
nanofibrous mats would provide multifunctional scaffolds properties for possible skin engineering, wound 
healing system and anti-carcinogenic drug deliver application for melanoma skin cancer. 
5.2 Future Research Guidelines 
Upon completion of this doctoral thesis, it is likely to think that we could improve and add some scientific 
knowledge to this related field. Notwithstanding, it is also a very common feeling that although we have 
conducted an important and relevant work, it is not fully finished and it possesses a lot of new possibilities 
and alternatives to enrich and explore. Bearing this idea, it is true to believe that this presented work can 
be thought as an initial matrix and start point for further investigations, which might contribute a better 
understanding and promoter better insights to the scientific community. Future work in this topic may 
lead to wider and encompass other nanotechnological and biofunctionalization of electrospun mats to 
accelerate wound healing process, promote skin reconstruction, enhance drug delivery copolymers to the 
target carcinogenic cells, hoping in the near future to delivery this idea to the market, providing better the 
patient´s perspective of life, health and wellbeing, minimizing the suffering and side effect commonly 
reported in patient´s under traditional cancer approaches such as chemo and radiotherapy.    
Thus, in order to complement and enhance the present doctoral investigation, we intend and propose in 
the near future to develop new experimental and practical framework, developing a supplementary set of 
trial aiming at: 
• Investigate the developed electrospun mats and its cell viability to melanocytes and keratinocytes 
cells; 
• Promote antimicrobial test in order to evaluate their effectiveness in bacterial strains, especially 
in Staphylococcus aureus, MRSA, Klebsiella pneumonia; 
• Develop a scaffold that could mimic the skin surface for the clinical trial, containing keratinocytes, 
melanocytes, human dermal fibroblast and melanoma cells; 
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• Try new technique as 3D printing technology for the development of new biofunctional materials; 
• Perform in vivo test, to gain better insights of the developed electrospun scaffolds and their 
interactions to body; 
• If possible, in the future, to develop clinical trial in hospital facilities where the scaffolds would be 
put under real circumstance and conditions, aiming to ascertain the new alternative approach for 
the patient´s diagnosed with melanoma; 
• Study the economic and health impact of the scaffolds in the medical environment.   
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